Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
FIB.interstitial.immune_interact: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 2,970 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nerve entrapment syndrome | NEURO000028 | 40.32 | Neurologic | Stromal / connective | 19 | 4 | 7 | 12 | |
| 2 | Heel quantitative ultrasound | MSKEL000005 | 35.90 | Musculoskeletal | Stromal / connective | 361 | 3 | 8 | 12 | |
| 3 | Waist circumference, adjusted for BMI | BMORP000006 | 35.50 | Body morphology | Stromal / connective | 314 | 3 | 3 | 9 | |
| 4 | Arm impedance | BCOMP000013 | 32.91 | Body composition | Stromal / connective | 665 | 4 | 6 | 12 | |
| 5 | TNXB levels | PROLV002085 | 32.03 | Protein levels | Stromal / connective | 56 | 4 | 7 | 22 | |
| 6 | Lean mass | BCOMP000009 | 31.04 | Body composition | Stromal / connective | 897 | 4 | 7 | 8 | |
| 7 | Height | BMORP000009 | 31.01 | Body morphology | Stromal / connective | 3,280 | 3 | 4 | 6 | |
| 8 | Bone mineral density | MSKEL000004 | 30.20 | Musculoskeletal | Stromal / connective | 350 | 3 | 8 | 10 | |
| 9 | Hip index | BMORP000012 | 29.89 | Body morphology | Adipose | 121 | 3 | 4 | 14 | |
| 10 | ROBO2 levels | PROLV001750 | 28.76 | Protein levels | Adipose | 69 | 5 | 10 | 24 | |
| 11 | Corneal properties | OPHTH000010 | 28.40 | Ophthalmic | Stromal / connective | 279 | 3 | 5 | 10 | |
| 12 | Whole body impedance | BCOMP000007 | 27.92 | Body composition | Stromal / connective | 553 | 5 | 7 | 15 | |
| 13 | Body size, adult | BMORP000003 | 27.52 | Body morphology | Stromal / connective | 300 | 3 | 6 | 8 | |
| 14 | CBLN4 levels | PROLV000272 | 26.78 | Protein levels | Adipose | 11 | 2 | 8 | 9 | |
| 15 | HSPG2/IGFBP6 ratio | PRORT001307 | 26.12 | Protein ratios | Adipose | 15 | 3 | 9 | 18 | |
| 16 | A body shape index, ABSI | BMORP000001 | 25.85 | Body morphology | Stromal / connective | 203 | 3 | 6 | 12 | |
| 17 | Leg impedance | BCOMP000016 | 25.69 | Body composition | Stromal / connective | 562 | 4 | 7 | 19 | |
| 18 | Intraocular pressure | OPHTH000011 | 25.21 | Ophthalmic | Stromal / connective | 184 | 4 | 6 | 10 | |
| 19 | Hip circumference, adjusted for BMI | BMORP000005 | 25.08 | Body morphology | Stromal / connective | 326 | 5 | 6 | 10 | |
| 20 | Operation, hernia | GASTR000040 | 24.87 | Gastrointestinal | Adipose | 21 | 2 | 5 | 9 | |
| 21 | Pelvic morphology | BMORP000021 | 23.75 | Body morphology | Stromal / connective | 54 | 3 | 5 | 6 | |
| 22 | Waist-hip ratio | BMORP000014 | 23.56 | Body morphology | Adipose | 523 | 3 | 5 | 10 | |
| 23 | COL6A3/CST3 ratio | PRORT000696 | 23.37 | Protein ratios | Adipose | 33 | 3 | 8 | 18 | |
| 24 | Physical function | MISCL000041 | 22.91 | Miscellaneous | Stromal / connective | 502 | 3 | 4 | 9 | |
| 25 | Ankle spacing width | MSKEL000056 | 22.82 | Musculoskeletal | Stromal / connective | 338 | 2 | 5 | 6 | |
| 26 | EGFR/FAP ratio | PRORT001000 | 22.33 | Protein ratios | Adipose | 52 | 4 | 8 | 17 | |
| 27 | Spinal deformity | MSKEL000077 | 21.57 | Musculoskeletal | Stromal / connective | 0 | 2 | 5 | 13 | |
| 28 | RET levels | PROLV001724 | 21.51 | Protein levels | Stromal / connective | 18 | 5 | 10 | 21 | |
| 29 | SCARA5 levels | PROLV001780 | 21.36 | Protein levels | Stromal / connective | 8 | 2 | 4 | 9 | |
| 30 | Hand grip strength | MSKEL000030 | 21.20 | Musculoskeletal | Stromal / connective | 131 | 5 | 7 | 13 | |
| 31 | Body proportion | BMORP000019 | 20.88 | Body morphology | Stromal / connective | 71 | 3 | 8 | 8 | |
| 32 | VCAN levels | PROLV002156 | 20.73 | Protein levels | Adipose | 116 | 3 | 8 | 21 | |
| 33 | Leukoencephalopathy | NEURO000004 | 20.55 | Neurologic | Stromal / connective | 2 | 2 | 10 | 7 | |
| 34 | CNTN1 levels | PROLV000475 | 20.32 | Protein levels | Stromal / connective | 121 | 4 | 10 | 25 | |
| 35 | COL6A3/SMOC2 ratio | PRORT000700 | 20.20 | Protein ratios | Adipose | 34 | 4 | 6 | 17 | |
| 36 | Forced vital capacity, FVC | RESPI000020 | 19.93 | Respiratory | Stromal / connective | 487 | 4 | 6 | 8 | |
| 37 | PSPN levels | PROLV001661 | 19.83 | Protein levels | Stromal / connective | 26 | 4 | 9 | 11 | |
| 38 | BOC levels | PROLV000207 | 19.57 | Protein levels | Stromal / connective | 7 | 5 | 15 | 42 | |
| 39 | Hernia | GASTR000008 | 19.42 | Gastrointestinal | Stromal / connective | 183 | 2 | 4 | 8 | |
| 40 | IGFBP6/SMOC2 ratio | PRORT001338 | 19.31 | Protein ratios | Adipose | 2 | 3 | 8 | 13 | |
| 41 | Corneal keratometry | OPHTH000006 | 19.12 | Ophthalmic | Stromal / connective | 298 | 3 | 5 | 8 | |
| 42 | Blood pressure, BP, pulse | VASCU000010 | 18.99 | Vascular | Stromal / connective | 1,008 | 5 | 7 | 16 | |
| 43 | ROBO2/SCARF2 ratio | PRORT001745 | 18.93 | Protein ratios | Adipose | 12 | 4 | 10 | 12 | |
| 44 | EFEMP1/TGFBR3 ratio | PRORT000988 | 18.39 | Protein ratios | Stromal / connective | 5 | 3 | 7 | 15 | |
| 45 | DLK1/FAP ratio | PRORT000911 | 17.94 | Protein ratios | Adipose | 26 | 4 | 8 | 25 | |
| 46 | COL6A3/COLEC12 ratio | PRORT000695 | 17.71 | Protein ratios | Adipose | 53 | 4 | 9 | 18 | |
| 47 | ZNRF4 levels | PROLV002214 | 17.56 | Protein levels | Adipose | 7 | 5 | 11 | 14 | |
| 48 | TNC levels | PROLV002052 | 17.35 | Protein levels | Adipose | 35 | 2 | 6 | 11 | |
| 49 | Hyperthyroidism, subclinical in pregnancy | ENDOC000011 | 17.34 | Endocrine | Adipose | 1 | 3 | 9 | 14 | |
| 50 | COMP/MYOC ratio | PRORT000712 | 16.37 | Protein ratios | Adipose | 3 | 4 | 14 | 23 | |
| 51 | COL24A1 levels | PROLV000486 | 16.23 | Protein levels | Stromal / connective | 2 | 5 | 10 | 25 | |
| 52 | Trunk mass | BCOMP000019 | 16.21 | Body composition | Stromal / connective | 381 | 4 | 10 | 14 | |
| 53 | Medication, antiglaucoma | OPHTH000014 | 16.07 | Ophthalmic | Stromal / connective | 69 | 2 | 5 | 12 | |
| 54 | CLMP/PIK3IP1 ratio | PRORT000669 | 15.95 | Protein ratios | Adipose | 1 | 3 | 6 | 10 | |
| 55 | BCAN/DPP6 ratio | PRORT000215 | 15.89 | Protein ratios | Stromal / connective | 0 | 5 | 11 | 20 | |
| 56 | FAP levels | PROLV000769 | 15.65 | Protein levels | Adipose | 78 | 7 | 12 | 27 | |
| 57 | PRELP levels | PROLV001627 | 15.33 | Protein levels | Stromal / connective | 71 | 4 | 9 | 11 | |
| 58 | Bone fragility disorder | MSKEL000007 | 15.32 | Musculoskeletal | Adipose | 23 | 5 | 15 | 25 | |
| 59 | Diverticular disease | GASTR000011 | 15.24 | Gastrointestinal | Stromal / connective | 95 | 3 | 6 | 17 | |
| 60 | COL6A3/OGN ratio | PRORT000699 | 14.98 | Protein ratios | Adipose | 33 | 5 | 8 | 16 | |
| 61 | C21orf58 levels | PROLV000231 | 14.94 | Protein levels | Hepatocyte | 0 | 4 | 10 | 17 | |
| 62 | Aortic valve disease | CARDI000053 | 14.55 | Cardiac | Vascular | 83 | 5 | 9 | 17 | |
| 63 | Acquired foot deformities | MSKEL000052 | 14.49 | Musculoskeletal | Stromal / connective | 38 | 2 | 5 | 12 | |
| 64 | Forced expiratory volume, FEV | RESPI000019 | 14.32 | Respiratory | Stromal / connective | 370 | 1 | 5 | 13 | |
| 65 | RFC4 levels | PROLV001726 | 14.30 | Protein levels | Stromal / connective | 1 | 4 | 14 | 19 | |
| 66 | Consultant specialty, ophthalmology | MISCL000018 | 14.26 | Miscellaneous | Vascular | 0 | 4 | 12 | 22 | |
| 67 | NPL levels | PROLV001423 | 14.09 | Protein levels | Myeloid | 36 | 4 | 8 | 19 | |
| 68 | VNN2 levels | PROLV002165 | 14.07 | Protein levels | Myeloid | 72 | 2 | 11 | 14 | |
| 69 | Atrial volume | CARDI000009 | 13.91 | Cardiac | Stromal / connective | 0 | 3 | 9 | 19 | |
| 70 | Prolapse, pelvic organ | REPRO000025 | 13.76 | Reproductive | Stromal / connective | 35 | 3 | 6 | 13 | |
| 71 | BPIFB1/GLRX ratio | PRORT000245 | 13.55 | Protein ratios | Adipose | 0 | 4 | 9 | 18 | |
| 72 | FGR levels | PROLV000804 | 13.52 | Protein levels | Adipose | 16 | 7 | 15 | 30 | |
| 73 | Cardiac angiography | CARDI000047 | 13.45 | Cardiac | Stromal / connective | 14 | 3 | 8 | 17 | |
| 74 | Body water mass | BCOMP000006 | 13.39 | Body composition | Stromal / connective | 324 | 5 | 10 | 21 | |
| 75 | EIF4G1/TBC1D23 ratio | PRORT001014 | 13.34 | Protein ratios | Adipose | 1 | 3 | 7 | 13 | |
| 76 | BCL2 levels | PROLV000185 | 13.32 | Protein levels | Lymphocyte | 0 | 5 | 18 | 27 | |
| 77 | Retinal and choroidal disorder | OPHTH000038 | 13.27 | Ophthalmic | Stromal / connective | 74 | 4 | 9 | 18 | |
| 78 | Spondylolisthesis or spondylolysis | MSKEL000079 | 13.25 | Musculoskeletal | Stromal / connective | 0 | 3 | 5 | 13 | |
| 79 | Fasciectomy | MSKEL000045 | 13.13 | Musculoskeletal | Stromal / connective | 11 | 3 | 8 | 14 | |
| 80 | MAMDC2 levels | PROLV001258 | 13.02 | Protein levels | Stromal / connective | 36 | 5 | 8 | 14 | |
| 81 | Coronary artery calcification | VASCU000055 | 12.97 | Vascular | Vascular | 56 | 4 | 6 | 11 | |
| 82 | Fibroblastic disorder | MSKEL000064 | 12.95 | Musculoskeletal | Stromal / connective | 49 | 3 | 6 | 10 | |
| 83 | COMP/DPP4 ratio | PRORT000709 | 12.87 | Protein ratios | Myeloid | 32 | 4 | 13 | 18 | |
| 84 | CTSD/PRCP ratio | PRORT000799 | 12.85 | Protein ratios | Hepatocyte | 16 | 2 | 10 | 21 | |
| 85 | Lens replacement | OPHTH000025 | 12.71 | Ophthalmic | Vascular | 12 | 2 | 13 | 17 | |
| 86 | COL4A1 levels | PROLV000490 | 12.69 | Protein levels | Hepatocyte | 117 | 3 | 10 | 16 | |
| 87 | ADAMTS8 levels | PROLV000035 | 12.62 | Protein levels | Muscle / cardiac | 48 | 3 | 5 | 11 | |
| 88 | CD34 levels | PROLV000336 | 12.50 | Protein levels | Stromal / connective | 67 | 3 | 10 | 21 | |
| 89 | HSPG2/SMOC2 ratio | PRORT001309 | 12.45 | Protein ratios | Stromal / connective | 32 | 4 | 9 | 16 | |
| 90 | Tympanic membrane perforation | AUDIO000019 | 12.33 | Auditory | Stromal / connective | 5 | 3 | 6 | 8 | |
| 91 | TNC/VCAM1 ratio | PRORT001843 | 12.30 | Protein ratios | Adipose | 38 | 3 | 10 | 13 | |
| 92 | Arm mass | BCOMP000014 | 12.21 | Body composition | Stromal / connective | 302 | 4 | 9 | 13 | |
| 93 | Medication, macular degeneration | OPHTH000015 | 12.19 | Ophthalmic | Hepatocyte | 41 | 3 | 11 | 20 | |
| 94 | Knee extension strength | MSKEL000031 | 12.06 | Musculoskeletal | Stromal / connective | 0 | 2 | 6 | 10 | |
| 95 | HMCN2 levels | PROLV000977 | 11.87 | Protein levels | Stromal / connective | 14 | 5 | 10 | 18 | |
| 96 | Precerebral arterial stenosis and occlusion | VASCU000016 | 11.83 | Vascular | Stromal / connective | 91 | 2 | 11 | 22 | |
| 97 | CDON levels | PROLV000385 | 11.64 | Protein levels | Granulosa cell | 4 | 5 | 10 | 14 | |
| 98 | Aortic aneurysm | VASCU000002 | 11.62 | Vascular | Vascular | 163 | 5 | 11 | 20 | |
| 99 | Musculoskeletal soft tissue disorder | MSKEL000029 | 11.53 | Musculoskeletal | Stromal / connective | 30 | 4 | 7 | 17 | |
| 100 | Fat-free mass | BCOMP000008 | 11.53 | Body composition | Stromal / connective | 273 | 6 | 9 | 12 | |
| 101 | Haemorrhoidal disease | VASCU000062 | 11.45 | Vascular | Vascular | 67 | 4 | 9 | 16 | |
| 102 | CCN3/FAP ratio | PRORT000373 | 11.38 | Protein ratios | Hepatocyte | 27 | 4 | 11 | 24 | |
| 103 | LAMB1 levels | PROLV001179 | 11.33 | Protein levels | Stromal / connective | 44 | 2 | 9 | 22 | |
| 104 | DLK1/PIK3IP1 ratio | PRORT000912 | 11.33 | Protein ratios | Stromal / connective | 1 | 4 | 10 | 35 | |
| 105 | PSG1 levels | PROLV001656 | 11.19 | Protein levels | Myeloid | 41 | 4 | 13 | 21 | |
| 106 | CD200R1 levels | PROLV000317 | 11.07 | Protein levels | Adipose | 54 | 2 | 5 | 14 | |
| 107 | MATN2 levels | PROLV001277 | 11.04 | Protein levels | Stromal / connective | 78 | 3 | 6 | 14 | |
| 108 | ADGRD1 levels | PROLV000041 | 11.04 | Protein levels | Hepatocyte | 47 | 5 | 12 | 15 | |
| 109 | Intestinal infection | IMMUN000066 | 11.01 | Immunologic | Vascular | 5 | 3 | 7 | 15 | |
| 110 | Heart failure, with coronary heart disease | CARDI000005 | 10.98 | Cardiac | Stromal / connective | 54 | 3 | 9 | 17 | |
| 111 | COLEC12/OGN ratio | PRORT000705 | 10.96 | Protein ratios | Stromal / connective | 12 | 3 | 11 | 19 | |
| 112 | FCRL2/TNFRSF13B ratio | PRORT001132 | 10.89 | Protein ratios | B / plasma cell | 10 | 3 | 8 | 18 | |
| 113 | Osteoporosis | MSKEL000010 | 10.88 | Musculoskeletal | Stromal / connective | 5 | 3 | 5 | 21 | |
| 114 | Aortic diameter | VASCU000052 | 10.81 | Vascular | Muscle / cardiac | 215 | 5 | 7 | 19 | |
| 115 | Lens disorder | OPHTH000013 | 10.79 | Ophthalmic | Stromal / connective | 3 | 5 | 8 | 10 | |
| 116 | EGFR levels | PROLV000687 | 10.69 | Protein levels | Adipose | 22 | 3 | 10 | 13 | |
| 117 | Thigh muscle volume | BMORP000020 | 10.63 | Body morphology | Muscle / cardiac | 16 | 4 | 8 | 17 | |
| 118 | ENG levels | PROLV000704 | 10.63 | Protein levels | Adipose | 10 | 4 | 12 | 30 | |
| 119 | DPP6/SEZ6L ratio | PRORT000947 | 10.62 | Protein ratios | Adipose | 8 | 3 | 10 | 14 | |
| 120 | LTBP2 levels | PROLV001242 | 10.59 | Protein levels | Myeloid | 145 | 4 | 14 | 23 | |
| 121 | Medication, antithrombotic | VASCU000033 | 10.48 | Vascular | Vascular | 37 | 4 | 10 | 12 | |
| 122 | CREG1/NAAA ratio | PRORT000752 | 10.44 | Protein ratios | Granulosa cell | 9 | 3 | 11 | 23 | |
| 123 | Retinal detachments and defects | OPHTH000039 | 10.34 | Ophthalmic | Stromal / connective | 2 | 3 | 7 | 22 | |
| 124 | Glaucoma | OPHTH000009 | 10.19 | Ophthalmic | Stromal / connective | 407 | 3 | 7 | 9 | |
| 125 | CHCHD10 levels | PROLV000424 | 10.16 | Protein levels | Muscle / cardiac | 0 | 4 | 8 | 21 | |
| 126 | COL6A3/HSPG2 ratio | PRORT000697 | 10.05 | Protein ratios | Stromal / connective | 49 | 3 | 7 | 15 | |
| 127 | FAP/THBS4 ratio | PRORT001117 | 10.04 | Protein ratios | Hepatocyte | 21 | 4 | 12 | 33 | |
| 128 | DLK1 levels | PROLV000625 | 10.02 | Protein levels | Muscle / cardiac | 29 | 4 | 9 | 25 | |
| 129 | Female genital disorder | REPRO000006 | 9.89 | Reproductive | Stromal / connective | 14 | 4 | 9 | 13 | |
| 130 | CD109 levels | PROLV000309 | 9.86 | Protein levels | Neural / glial | 31 | 4 | 14 | 36 | |
| 131 | CD164/PARK7 ratio | PRORT000389 | 9.72 | Protein ratios | Neural / glial | 0 | 6 | 10 | 25 | |
| 132 | PRTG levels | PROLV001650 | 9.69 | Protein levels | Hepatocyte | 34 | 4 | 11 | 17 | |
| 133 | ADAMTSL2 levels | PROLV000036 | 9.62 | Protein levels | Hepatocyte | 72 | 3 | 14 | 23 | |
| 134 | Carotid intima-media thickness | VASCU000053 | 9.61 | Vascular | Adipose | 15 | 2 | 5 | 12 | |
| 135 | ADGRB3 levels | PROLV000040 | 9.56 | Protein levels | Stromal / connective | 34 | 5 | 8 | 25 | |
| 136 | SLITRK6 levels | PROLV001890 | 9.54 | Protein levels | Adipose | 4 | 2 | 11 | 17 | |
| 137 | CDON/SCARA5 ratio | PRORT000581 | 9.44 | Protein ratios | Adipose | 51 | 3 | 7 | 11 | |
| 138 | COMP levels | PROLV000496 | 9.37 | Protein levels | Myeloid | 133 | 3 | 11 | 17 | |
| 139 | FEV1/FVC ratio | RESPI000021 | 9.34 | Respiratory | Stromal / connective | 549 | 3 | 4 | 17 | |
| 140 | Carpal tunnel surgery | MSKEL000044 | 9.29 | Musculoskeletal | Stromal / connective | 5 | 4 | 6 | 11 | |
| 141 | Barrett's oesophagus | GASTR000046 | 9.28 | Gastrointestinal | Stromal / connective | 11 | 2 | 6 | 14 | |
| 142 | PECAM1/SOD2 ratio | PRORT001662 | 9.28 | Protein ratios | Myeloid | 17 | 5 | 13 | 18 | |
| 143 | Aneurysm | VASCU000001 | 9.26 | Vascular | Hepatocyte | 141 | 4 | 8 | 22 | |
| 144 | AHCY/HSPA1A ratio | PRORT000055 | 9.23 | Protein ratios | Lymphocyte | 10 | 3 | 12 | 39 | |
| 145 | Diffuse idiopathic skeletal hyperostosis | MSKEL000074 | 9.22 | Musculoskeletal | Hematopoietic progenitor | 1 | 2 | 6 | 16 | |
| 146 | FUT8/TNFSF14 ratio | PRORT001192 | 9.21 | Protein ratios | Adipose | 13 | 4 | 22 | 56 | |
| 147 | VWF levels | PROLV002182 | 9.12 | Protein levels | Vascular | 12 | 2 | 5 | 13 | |
| 148 | APOF levels | PROLV000125 | 9.11 | Protein levels | Hepatocyte | 56 | 4 | 10 | 22 | |
| 149 | ANGPTL7 levels | PROLV000099 | 9.06 | Protein levels | Stromal / connective | 32 | 2 | 9 | 13 | |
| 150 | Operation, vascular | VASCU000058 | 9.04 | Vascular | Vascular | 116 | 4 | 7 | 10 | |
| 151 | FAP/LRRN1 ratio | PRORT001116 | 8.94 | Protein ratios | Muscle / cardiac | 42 | 5 | 15 | 34 | |
| 152 | Eye disorder | OPHTH000008 | 8.94 | Ophthalmic | Neural / glial | 4 | 1 | 1 | 7 | |
| 153 | Leg mass | BCOMP000017 | 8.91 | Body composition | Neural / glial | 384 | 5 | 10 | 15 | |
| 154 | Medication, post-myocardial infarction | CARDI000045 | 8.90 | Cardiac | Vascular | 76 | 4 | 9 | 11 | |
| 155 | MSMB levels | PROLV001341 | 8.86 | Protein levels | Stromal / connective | 32 | 3 | 9 | 14 | |
| 156 | Trunk fat percentage | BCOMP000018 | 8.83 | Body composition | Neural / glial | 276 | 3 | 10 | 17 | |
| 157 | CTSZ/NAAA ratio | PRORT000805 | 8.82 | Protein ratios | Stromal / connective | 45 | 2 | 10 | 14 | |
| 158 | FNDC1 levels | PROLV000820 | 8.78 | Protein levels | Hepatocyte | 14 | 3 | 13 | 22 | |
| 159 | PILRA/TNFRSF1A ratio | PRORT001668 | 8.77 | Protein ratios | Adipose | 42 | 2 | 9 | 13 | |
| 160 | MXRA8 levels | PROLV001355 | 8.75 | Protein levels | Myeloid | 78 | 5 | 12 | 24 | |
| 161 | COL6A3/TAFA5 ratio | PRORT000702 | 8.72 | Protein ratios | Hepatocyte | 31 | 5 | 7 | 24 | |
| 162 | PSME2/RBKS ratio | PRORT001713 | 8.70 | Protein ratios | Hepatocyte | 23 | 4 | 15 | 13 | |
| 163 | Sulcal opening distance | NIMAG000012 | 8.69 | Neuroimaging | Vascular | 11 | 5 | 9 | 18 | |
| 164 | SIL1 levels | PROLV001866 | 8.67 | Protein levels | Stromal / connective | 1 | 4 | 14 | 21 | |
| 165 | CD79B/FCRL2 ratio | PRORT000511 | 8.65 | Protein ratios | Stromal / connective | 17 | 2 | 7 | 12 | |
| 166 | White matter lesion volume | NIMAG000027 | 8.63 | Neuroimaging | Stromal / connective | 30 | 4 | 10 | 14 | |
| 167 | AOC3 levels | PROLV000109 | 8.63 | Protein levels | Myeloid | 116 | 4 | 13 | 22 | |
| 168 | ITGAM/ITGAV ratio | PRORT001375 | 8.63 | Protein ratios | Myeloid | 72 | 4 | 16 | 25 | |
| 169 | C7 levels | PROLV000236 | 8.61 | Protein levels | Adipose | 12 | 2 | 11 | 27 | |
| 170 | Intracerebral haemorrhage | VASCU000014 | 8.59 | Vascular | Stromal / connective | 0 | 6 | 14 | 20 | |
| 171 | PLXDC2 levels | PROLV001584 | 8.56 | Protein levels | Granulosa cell | 18 | 4 | 16 | 23 | |
| 172 | CILP levels | PROLV000436 | 8.52 | Protein levels | Myeloid | 47 | 5 | 12 | 21 | |
| 173 | Intracranial volume | NIMAG000025 | 8.45 | Neuroimaging | Muscle / cardiac | 0 | 3 | 8 | 18 | |
| 174 | Mammary dysplasia | BREAS000001 | 8.42 | Breast | Adipose | 0 | 1 | 8 | 17 | |
| 175 | Skin sebum | DERMA000036 | 8.42 | Dermatologic | Stromal / connective | 0 | 2 | 6 | 12 | |
| 176 | CST3/IGFBP6 ratio | PRORT000783 | 8.40 | Protein ratios | Stromal / connective | 7 | 3 | 15 | 19 | |
| 177 | DPP4/ITGB1 ratio | PRORT000944 | 8.34 | Protein ratios | Myeloid | 11 | 3 | 12 | 25 | |
| 178 | Knee morphology | MSKEL000024 | 8.33 | Musculoskeletal | Stromal / connective | 0 | 4 | 7 | 17 | |
| 179 | Aortic elasticity | VASCU000049 | 8.22 | Vascular | Vascular | 20 | 3 | 5 | 12 | |
| 180 | DKKL1 levels | PROLV000623 | 8.18 | Protein levels | Hepatocyte | 77 | 4 | 10 | 25 | |
| 181 | HGF/TNFSF14 ratio | PRORT001286 | 8.17 | Protein ratios | Hepatocyte | 19 | 5 | 14 | 27 | |
| 182 | SRPX levels | PROLV001945 | 8.17 | Protein levels | Adipose | 32 | 4 | 10 | 16 | |
| 183 | DPP4 levels | PROLV000646 | 8.15 | Protein levels | Myeloid | 44 | 3 | 12 | 22 | |
| 184 | GSTA4 levels | PROLV000941 | 8.14 | Protein levels | Adipose | 0 | 2 | 16 | 26 | |
| 185 | TNFRSF4/TNFRSF9 ratio | PRORT001854 | 8.13 | Protein ratios | Stromal / connective | 5 | 2 | 8 | 18 | |
| 186 | MATN2/SCARA5 ratio | PRORT001494 | 8.10 | Protein ratios | Stromal / connective | 12 | 5 | 9 | 19 | |
| 187 | ACVRL1/TNFRSF19 ratio | PRORT000017 | 8.09 | Protein ratios | Vascular | 20 | 2 | 7 | 15 | |
| 188 | CTSO/IGF2R ratio | PRORT000803 | 8.07 | Protein ratios | Hepatocyte | 20 | 4 | 13 | 26 | |
| 189 | CALCA levels | PROLV000255 | 8.07 | Protein levels | Stromal / connective | 6 | 4 | 7 | 22 | |
| 190 | CLMP/TNFRSF19 ratio | PRORT000671 | 8.03 | Protein ratios | Stromal / connective | 0 | 2 | 3 | 9 | |
| 191 | Basal metabolic rate | METBL000007 | 7.97 | Metabolic | Neural / glial | 298 | 6 | 10 | 20 | |
| 192 | ERBB3 levels | PROLV000725 | 7.96 | Protein levels | Hepatocyte | 97 | 4 | 10 | 20 | |
| 193 | TGFBR3 levels | PROLV002023 | 7.94 | Protein levels | Adipose | 33 | 3 | 6 | 14 | |
| 194 | ST6GALNAC2 levels | PROLV001954 | 7.89 | Protein levels | Neural / glial | 11 | 3 | 8 | 11 | |
| 195 | PKD1 levels | PROLV001564 | 7.89 | Protein levels | Vascular | 84 | 4 | 11 | 19 | |
| 196 | CST3/TFF3 ratio | PRORT000788 | 7.86 | Protein ratios | Adipose | 7 | 1 | 9 | 12 | |
| 197 | Spinal stenosis | MSKEL000078 | 7.77 | Musculoskeletal | Stromal / connective | 43 | 4 | 9 | 11 | |
| 198 | TPM2 levels | PROLV002095 | 7.72 | Protein levels | Hepatocyte | 9 | 3 | 10 | 17 | |
| 199 | Fasciitis | MSKEL000063 | 7.72 | Musculoskeletal | Stromal / connective | 16 | 1 | 3 | 8 | |
| 200 | Kidney volume | NEPHR000022 | 7.72 | Nephrourologic | Stromal / connective | 1 | 3 | 8 | 25 | |
| 201 | S100A12 levels | PROLV001767 | 7.67 | Protein levels | Lymphocyte | 6 | 3 | 14 | 39 | |
| 202 | L1CAM levels | PROLV001171 | 7.62 | Protein levels | Vascular | 70 | 6 | 12 | 37 | |
| 203 | CCDC80/CCL27 ratio | PRORT000332 | 7.60 | Protein ratios | Myeloid | 40 | 3 | 6 | 28 | |
| 204 | Joint disorder | MSKEL000015 | 7.60 | Musculoskeletal | Stromal / connective | 2 | 3 | 10 | 14 | |
| 205 | COMP/ITGAV ratio | PRORT000711 | 7.55 | Protein ratios | Myeloid | 58 | 3 | 11 | 18 | |
| 206 | DNAJA2/HPCAL1 ratio | PRORT000922 | 7.55 | Protein ratios | Myeloid | 2 | 5 | 16 | 37 | |
| 207 | CXCL10/WARS ratio | PRORT000815 | 7.51 | Protein ratios | Hepatocyte | 4 | 2 | 9 | 17 | |
| 208 | ESR1 levels | PROLV000735 | 7.47 | Protein levels | Adipose | 0 | 3 | 13 | 27 | |
| 209 | IGF1 levels | PROLV001025 | 7.42 | Protein levels | Hepatocyte | 1,341 | 1 | 7 | 13 | |
| 210 | Cardiac procedure, angioplasty | VASCU000057 | 7.39 | Vascular | Vascular | 102 | 4 | 10 | 20 | |
| 211 | AXL/MSR1 ratio | PRORT000182 | 7.37 | Protein ratios | Myeloid | 28 | 4 | 16 | 18 | |
| 212 | Macular puckering of retina | OPHTH000037 | 7.37 | Ophthalmic | Stromal / connective | 17 | 3 | 8 | 11 | |
| 213 | OLR1 levels | PROLV001467 | 7.35 | Protein levels | Myeloid | 37 | 2 | 7 | 17 | |
| 214 | Visual impairment | OPHTH000046 | 7.32 | Ophthalmic | Stromal / connective | 28 | 0 | 2 | 7 | |
| 215 | TNFRSF14/TNFSF14 ratio | PRORT001851 | 7.28 | Protein ratios | Hepatocyte | 14 | 3 | 15 | 47 | |
| 216 | HJV levels | PROLV000971 | 7.27 | Protein levels | Hepatocyte | 12 | 4 | 12 | 35 | |
| 217 | VIT levels | PROLV002162 | 7.18 | Protein levels | Myeloid | 11 | 6 | 14 | 27 | |
| 218 | NTPROBNP levels | PROLV001446 | 7.18 | Protein levels | Muscle / cardiac | 50 | 2 | 7 | 18 | |
| 219 | SFRP4 levels | PROLV001846 | 7.17 | Protein levels | Stromal / connective | 10 | 3 | 7 | 9 | |
| 220 | MYOC/NOTCH3 ratio | PRORT001566 | 7.16 | Protein ratios | Hepatocyte | 9 | 1 | 8 | 24 | |
| 221 | LGALS3 levels | PROLV001202 | 7.13 | Protein levels | Vascular | 28 | 1 | 2 | 8 | |
| 222 | Ventricular mass-to-volume ratio | CARDI000013 | 7.10 | Cardiac | Muscle / cardiac | 40 | 3 | 5 | 17 | |
| 223 | INHBB levels | PROLV001087 | 7.10 | Protein levels | Hepatocyte | 38 | 6 | 10 | 14 | |
| 224 | SCARF2 levels | PROLV001783 | 7.10 | Protein levels | Adipose | 49 | 2 | 6 | 11 | |
| 225 | PTPRZ1 levels | PROLV001682 | 7.08 | Protein levels | Myeloid | 82 | 3 | 10 | 17 | |
| 226 | ERBB2 levels | PROLV000724 | 7.07 | Protein levels | Hepatocyte | 97 | 1 | 8 | 17 | |
| 227 | BCAN/MOG ratio | PRORT000217 | 7.05 | Protein ratios | Myeloid | 5 | 1 | 6 | 12 | |
| 228 | Gynaecomastia | BREAS000003 | 7.02 | Breast | Granulosa cell | 0 | 1 | 4 | 11 | |
| 229 | HAMP levels | PROLV000950 | 7.00 | Protein levels | Vascular | 8 | 5 | 10 | 10 | |
| 230 | FAM3B/FGF19 ratio | PRORT001111 | 6.99 | Protein ratios | Hepatocyte | 18 | 2 | 7 | 14 | |
| 231 | COL6A3 levels | PROLV000492 | 6.99 | Protein levels | Stromal / connective | 38 | 2 | 4 | 12 | |
| 232 | Optic cup area | OPHTH000028 | 6.96 | Ophthalmic | Vascular | 5 | 3 | 9 | 14 | |
| 233 | DSG4 levels | PROLV000657 | 6.91 | Protein levels | Cutaneous epithelium | 24 | 1 | 7 | 10 | |
| 234 | GPA33 levels | PROLV000918 | 6.89 | Protein levels | Vascular | 66 | 2 | 10 | 11 | |
| 235 | PAMR1 levels | PROLV001493 | 6.89 | Protein levels | Myeloid | 137 | 3 | 13 | 23 | |
| 236 | AIFM1/EGF ratio | PRORT000059 | 6.88 | Protein ratios | Hepatocyte | 15 | 2 | 10 | 20 | |
| 237 | LAMP1 levels | PROLV001180 | 6.84 | Protein levels | Myeloid | 47 | 3 | 9 | 19 | |
| 238 | CHRDL1/SMOC2 ratio | PRORT000614 | 6.83 | Protein ratios | Adipose | 3 | 3 | 7 | 14 | |
| 239 | Acute appendicitis | GASTR000009 | 6.82 | Gastrointestinal | Myeloid | 28 | 1 | 2 | 7 | |
| 240 | Fracture | MSKEL000011 | 6.81 | Musculoskeletal | Stromal / connective | 27 | 1 | 1 | 1 | |
| 241 | DLK1/RGMB ratio | PRORT000913 | 6.78 | Protein ratios | Hepatocyte | 11 | 4 | 9 | 23 | |
| 242 | SCARA5/TNC ratio | PRORT001760 | 6.76 | Protein ratios | Granulosa cell | 39 | 2 | 9 | 13 | |
| 243 | BTN2A1/SMOC2 ratio | PRORT000260 | 6.76 | Protein ratios | Myeloid | 49 | 4 | 8 | 21 | |
| 244 | AGRN/HSPG2 ratio | PRORT000048 | 6.73 | Protein ratios | Stromal / connective | 22 | 7 | 7 | 25 | |
| 245 | HHIP levels | PROLV000969 | 6.70 | Protein levels | B / plasma cell | 0 | 3 | 9 | 16 | |
| 246 | Adhesive capsulitis | MSKEL000058 | 6.70 | Musculoskeletal | Stromal / connective | 26 | 1 | 5 | 13 | |
| 247 | CHCHD6 levels | PROLV000425 | 6.69 | Protein levels | Stromal / connective | 0 | 3 | 8 | 26 | |
| 248 | NRP1 levels | PROLV001434 | 6.68 | Protein levels | Hepatocyte | 128 | 2 | 10 | 21 | |
| 249 | CASP1 levels | PROLV000265 | 6.68 | Protein levels | Myeloid | 55 | 2 | 10 | 18 | |
| 250 | SFRP2 levels | PROLV001845 | 6.68 | Protein levels | Neural / glial | 11 | 4 | 8 | 24 | |
| 251 | FGF19/SCG2 ratio | PRORT001139 | 6.67 | Protein ratios | Hepatocyte | 29 | 2 | 8 | 13 | |
| 252 | Coronary artery plaque burden | VASCU000056 | 6.66 | Vascular | Vascular | 37 | 3 | 5 | 9 | |
| 253 | MYOC levels | PROLV001363 | 6.64 | Protein levels | Vascular | 33 | 0 | 5 | 12 | |
| 254 | CNTN5 levels | PROLV000479 | 6.63 | Protein levels | Myeloid | 1 | 4 | 6 | 13 | |
| 255 | CD40LG/TNFSF14 ratio | PRORT000454 | 6.62 | Protein ratios | Hepatocyte | 11 | 5 | 17 | 43 | |
| 256 | VSNL1 levels | PROLV002173 | 6.60 | Protein levels | Myeloid | 44 | 2 | 9 | 20 | |
| 257 | RBP5 levels | PROLV001712 | 6.59 | Protein levels | Adipose | 3 | 0 | 8 | 32 | |
| 258 | Coronary revascularization | VASCU000059 | 6.58 | Vascular | Vascular | 384 | 4 | 9 | 25 | |
| 259 | Trigger finger | MSKEL000072 | 6.57 | Musculoskeletal | Stromal / connective | 7 | 2 | 4 | 8 | |
| 260 | ITGBL1 levels | PROLV001117 | 6.57 | Protein levels | Vascular | 82 | 3 | 11 | 14 | |
| 261 | PLXDC1 levels | PROLV001583 | 6.56 | Protein levels | Adipose | 4 | 2 | 13 | 38 | |
| 262 | Arterial dissection | VASCU000003 | 6.52 | Vascular | Stromal / connective | 16 | 0 | 2 | 15 | |
| 263 | EFEMP1/FSTL3 ratio | PRORT000986 | 6.50 | Protein ratios | Stromal / connective | 14 | 4 | 6 | 20 | |
| 264 | Pregnancy complication, obstructed labour | REPRO000031 | 6.48 | Reproductive | Stromal / connective | 0 | 3 | 6 | 11 | |
| 265 | Peak expiratory flow | RESPI000023 | 6.47 | Respiratory | Stromal / connective | 305 | 2 | 5 | 8 | |
| 266 | Bone infection | IMMUN000053 | 6.47 | Immunologic | Myeloid | 0 | 3 | 10 | 24 | |
| 267 | ANGPTL4 levels | PROLV000098 | 6.45 | Protein levels | Hepatocyte | 49 | 3 | 9 | 23 | |
| 268 | DDR1 levels | PROLV000610 | 6.44 | Protein levels | Melanocyte | 92 | 3 | 14 | 23 | |
| 269 | SLC39A5 levels | PROLV001881 | 6.31 | Protein levels | Hepatocyte | 133 | 4 | 11 | 29 | |
| 270 | Macular degeneration | OPHTH000036 | 6.29 | Ophthalmic | Hepatocyte | 106 | 2 | 7 | 15 | |
| 271 | Angina pectoris | CARDI000039 | 6.28 | Cardiac | Vascular | 317 | 5 | 9 | 18 | |
| 272 | ANGPTL2 levels | PROLV000096 | 6.28 | Protein levels | Stromal / connective | 48 | 3 | 17 | 12 | |
| 273 | PON1 levels | PROLV001600 | 6.26 | Protein levels | Granulosa cell | 40 | 5 | 14 | 21 | |
| 274 | Brain neuroimaging feature | NIMAG000005 | 6.24 | Neuroimaging | Stromal / connective | 137 | 0 | 2 | 9 | |
| 275 | NAAA/SMPD1 ratio | PRORT001569 | 6.24 | Protein ratios | Granulosa cell | 6 | 3 | 12 | 20 | |
| 276 | CTSO levels | PROLV000567 | 6.21 | Protein levels | Myeloid | 112 | 2 | 11 | 27 | |
| 277 | TNN levels | PROLV002083 | 6.19 | Protein levels | Stromal / connective | 16 | 2 | 9 | 11 | |
| 278 | ITGAV levels | PROLV001110 | 6.19 | Protein levels | Hepatocyte | 116 | 4 | 14 | 24 | |
| 279 | Male-pattern baldness | DERMA000032 | 6.18 | Dermatologic | Stromal / connective | 74 | 0 | 4 | 6 | |
| 280 | Circulatory disorder | VASCU000025 | 6.16 | Vascular | Neural / glial | 1 | 1 | 5 | 14 | |
| 281 | DPP6/SEZ6L2 ratio | PRORT000948 | 6.13 | Protein ratios | Myeloid | 37 | 4 | 14 | 16 | |
| 282 | Ocular refraction | OPHTH000033 | 6.11 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 283 | CD59/CST6 ratio | PRORT000481 | 6.10 | Protein ratios | Respiratory epithelium | 3 | 0 | 12 | 7 | |
| 284 | ITGA11 levels | PROLV001104 | 6.10 | Protein levels | Hepatocyte | 66 | 3 | 11 | 20 | |
| 285 | COL15A1 levels | PROLV000483 | 6.09 | Protein levels | Stromal / connective | 4 | 0 | 6 | 11 | |
| 286 | Fatty acids, undecenoic acid | LIPID000030 | 6.08 | Lipids | Stromal / connective | 0 | 3 | 8 | 17 | |
| 287 | Medication, coronary artery disease | VASCU000037 | 6.02 | Vascular | Vascular | 121 | 5 | 8 | 17 | |
| 288 | REG4/SPINK4 ratio | PRORT001733 | 5.97 | Protein ratios | Myeloid | 0 | 0 | 2 | 10 | |
| 289 | GFRA1 levels | PROLV000876 | 5.96 | Protein levels | Myeloid | 22 | 2 | 8 | 15 | |
| 290 | IL13RA1 levels | PROLV001047 | 5.94 | Protein levels | Hepatocyte | 1 | 3 | 10 | 21 | |
| 291 | CTSL levels | PROLV000566 | 5.94 | Protein levels | Myeloid | 163 | 2 | 9 | 15 | |
| 292 | IFNGR1/THBD ratio | PRORT001332 | 5.92 | Protein ratios | Vascular | 22 | 3 | 9 | 14 | |
| 293 | ADGRE5/GAS6 ratio | PRORT000030 | 5.92 | Protein ratios | Myeloid | 116 | 4 | 10 | 23 | |
| 294 | Refractive errors | OPHTH000034 | 5.91 | Ophthalmic | Neural / glial | 133 | 1 | 6 | 9 | |
| 295 | MIA/NBL1 ratio | PRORT001532 | 5.87 | Protein ratios | Stromal / connective | 22 | 3 | 7 | 17 | |
| 296 | IL31RA levels | PROLV001071 | 5.85 | Protein levels | Granulosa cell | 1 | 3 | 7 | 13 | |
| 297 | Eyelid disorder | OPHTH000019 | 5.83 | Ophthalmic | Adipose | 14 | 1 | 1 | 3 | |
| 298 | Fall risk | MSKEL000043 | 5.80 | Musculoskeletal | Stromal / connective | 1 | 0 | 5 | 10 | |
| 299 | Body size, birth | BMORP000017 | 5.76 | Body morphology | Vascular | 12 | 2 | 6 | 9 | |
| 300 | Uterine or vaginal bleeding | REPRO000044 | 5.75 | Reproductive | Stromal / connective | 0 | 5 | 8 | 16 | |
| 301 | DNAJA2/PLXNA4 ratio | PRORT000923 | 5.74 | Protein ratios | Lymphocyte | 20 | 6 | 17 | 40 | |
| 302 | NXPH3 levels | PROLV001458 | 5.72 | Protein levels | Stromal / connective | 3 | 1 | 4 | 15 | |
| 303 | Benign neoplasm, Adipose | MALIG000001 | 5.71 | Malignancy | Adipose | 1 | 2 | 6 | 14 | |
| 304 | SPON1 levels | PROLV001936 | 5.70 | Protein levels | Vascular | 33 | 0 | 2 | 7 | |
| 305 | LTBP2/MYOC ratio | PRORT001464 | 5.70 | Protein ratios | Neural / glial | 0 | 3 | 8 | 16 | |
| 306 | IGDCC4 levels | PROLV001024 | 5.69 | Protein levels | Myeloid | 46 | 4 | 11 | 16 | |
| 307 | MIA levels | PROLV001311 | 5.68 | Protein levels | Neural / glial | 91 | 4 | 7 | 14 | |
| 308 | NEO1 levels | PROLV001392 | 5.67 | Protein levels | Muscle / cardiac | 0 | 3 | 11 | 19 | |
| 309 | BCAM levels | PROLV000181 | 5.67 | Protein levels | Hepatocyte | 79 | 2 | 14 | 15 | |
| 310 | IFIT2 levels | PROLV001016 | 5.67 | Protein levels | Myeloid | 17 | 5 | 9 | 20 | |
| 311 | PTPRF/PTPRS ratio | PRORT001721 | 5.66 | Protein ratios | Hepatocyte | 76 | 4 | 11 | 24 | |
| 312 | THBS2 levels | PROLV002026 | 5.64 | Protein levels | Lymphocyte | 30 | 2 | 11 | 39 | |
| 313 | ITGB1 levels | PROLV001111 | 5.63 | Protein levels | Myeloid | 78 | 4 | 10 | 28 | |
| 314 | FN1 levels | PROLV000819 | 5.63 | Protein levels | Myeloid | 76 | 5 | 15 | 27 | |
| 315 | NCAM1 levels | PROLV001377 | 5.62 | Protein levels | Muscle / cardiac | 119 | 4 | 11 | 24 | |
| 316 | COLEC12/TGFBR2 ratio | PRORT000707 | 5.62 | Protein ratios | Hepatocyte | 75 | 3 | 8 | 18 | |
| 317 | ALKBH3 levels | PROLV000080 | 5.61 | Protein levels | Myeloid | 0 | 4 | 14 | 18 | |
| 318 | NCAM2 levels | PROLV001378 | 5.55 | Protein levels | Myeloid | 33 | 3 | 7 | 17 | |
| 319 | ENPP7 levels | PROLV000711 | 5.55 | Protein levels | Hepatocyte | 60 | 2 | 10 | 22 | |
| 320 | Corneal disorder | OPHTH000003 | 5.54 | Ophthalmic | Stromal / connective | 11 | 1 | 1 | 14 | |
| 321 | IL3RA levels | PROLV001074 | 5.54 | Protein levels | Granulosa cell | 51 | 1 | 10 | 25 | |
| 322 | HSPG2 levels | PROLV000999 | 5.51 | Protein levels | Adipose | 16 | 2 | 5 | 13 | |
| 323 | ACYP1 levels | PROLV000021 | 5.51 | Protein levels | Lymphocyte | 14 | 2 | 12 | 34 | |
| 324 | RBP7 levels | PROLV001713 | 5.49 | Protein levels | Neural / glial | 36 | 3 | 9 | 11 | |
| 325 | Coronary artery disease, CAD | VASCU000020 | 5.49 | Vascular | Vascular | 661 | 3 | 10 | 23 | |
| 326 | CST6/NECTIN4 ratio | PRORT000792 | 5.46 | Protein ratios | Epithelial | 3 | 1 | 5 | 13 | |
| 327 | CR2/TNFRSF13B ratio | PRORT000738 | 5.42 | Protein ratios | B / plasma cell | 32 | 3 | 9 | 15 | |
| 328 | Ganglion cyst | MSKEL000065 | 5.41 | Musculoskeletal | Stromal / connective | 0 | 1 | 3 | 12 | |
| 329 | Gestational age at birth | REPRO000040 | 5.39 | Reproductive | Neural / glial | 0 | 1 | 7 | 10 | |
| 330 | EFNA1 levels | PROLV000681 | 5.38 | Protein levels | Vascular | 45 | 2 | 11 | 22 | |
| 331 | Serine | METAB000029 | 5.37 | Metabolites | Epithelial | 1 | 4 | 13 | 17 | |
| 332 | CD59/SCARB2 ratio | PRORT000483 | 5.37 | Protein ratios | Myeloid | 16 | 4 | 10 | 20 | |
| 333 | ASPN levels | PROLV000153 | 5.36 | Protein levels | Stromal / connective | 10 | 4 | 12 | 35 | |
| 334 | Wisdom tooth surgery | DENTA000005 | 5.36 | Dental | B / plasma cell | 0 | 7 | 15 | 30 | |
| 335 | DDHD2 levels | PROLV000609 | 5.35 | Protein levels | Vascular | 9 | 4 | 10 | 15 | |
| 336 | APOM/MCAM ratio | PRORT000119 | 5.33 | Protein ratios | Hepatocyte | 64 | 2 | 10 | 18 | |
| 337 | Valvular heart disease | CARDI000054 | 5.29 | Cardiac | Vascular | 15 | 5 | 9 | 24 | |
| 338 | Hip joint morphology | MSKEL000023 | 5.29 | Musculoskeletal | Stromal / connective | 56 | 2 | 4 | 7 | |
| 339 | AOC3/ITGB1 ratio | PRORT000113 | 5.28 | Protein ratios | Stromal / connective | 16 | 3 | 14 | 10 | |
| 340 | CCL27 levels | PROLV000294 | 5.24 | Protein levels | Myeloid | 146 | 2 | 10 | 16 | |
| 341 | Fibromuscular dysplasia | VASCU000024 | 5.24 | Vascular | Stromal / connective | 1 | 3 | 6 | 11 | |
| 342 | IL1R2 levels | PROLV001061 | 5.23 | Protein levels | Hepatocyte | 116 | 3 | 9 | 15 | |
| 343 | CREG1/SMPDL3A ratio | PRORT000753 | 5.22 | Protein ratios | Hepatocyte | 10 | 2 | 10 | 28 | |
| 344 | SELE levels | PROLV001803 | 5.22 | Protein levels | Vascular | 55 | 2 | 4 | 14 | |
| 345 | Snoring | RESPI000036 | 5.22 | Respiratory | Neural / glial | 12 | 3 | 11 | 32 | |
| 346 | AIFM1/PLXNA4 ratio | PRORT000060 | 5.22 | Protein ratios | Hepatocyte | 9 | 2 | 10 | 26 | |
| 347 | NHLRC3 levels | PROLV001403 | 5.19 | Protein levels | Stromal / connective | 23 | 5 | 9 | 27 | |
| 348 | Peripheral nerve disorder | NEURO000031 | 5.19 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 349 | FGF19 levels | PROLV000793 | 5.19 | Protein levels | Hepatocyte | 49 | 1 | 7 | 22 | |
| 350 | Rotator cuff injury | MSKEL000067 | 5.18 | Musculoskeletal | Stromal / connective | 0 | 3 | 7 | 17 | |
| 351 | ANGPTL3/TFPI ratio | PRORT000099 | 5.17 | Protein ratios | Hepatocyte | 73 | 2 | 11 | 18 | |
| 352 | CD70 levels | PROLV000353 | 5.17 | Protein levels | Muscle / cardiac | 6 | 3 | 11 | 20 | |
| 353 | ATXN2L levels | PROLV000165 | 5.13 | Protein levels | Stromal / connective | 0 | 1 | 6 | 16 | |
| 354 | TNFRSF12A levels | PROLV002062 | 5.09 | Protein levels | Epithelial | 11 | 0 | 7 | 6 | |
| 355 | COL18A1 levels | PROLV000484 | 5.08 | Protein levels | Stromal / connective | 55 | 3 | 7 | 12 | |
| 356 | FIS1/PDGFB ratio | PRORT001150 | 5.06 | Protein ratios | Myeloid | 14 | 2 | 8 | 23 | |
| 357 | SERPINA3 levels | PROLV001817 | 5.04 | Protein levels | Myeloid | 2 | 3 | 8 | 14 | |
| 358 | Digital deformity | MSKEL000053 | 5.03 | Musculoskeletal | Stromal / connective | 0 | 5 | 8 | 33 | |
| 359 | CHI3L1/HSPG2 ratio | PRORT000610 | 5.02 | Protein ratios | Hepatocyte | 10 | 2 | 9 | 26 | |
| 360 | Foot surgery | MSKEL000046 | 5.01 | Musculoskeletal | Hematopoietic progenitor | 2 | 2 | 6 | 12 | |
| 361 | CLK2 levels | PROLV000460 | 5.01 | Protein levels | Hepatocyte | 11 | 2 | 7 | 20 | |
| 362 | PLA2G15/PRCP ratio | PRORT001670 | 5.01 | Protein ratios | Myeloid | 44 | 3 | 11 | 21 | |
| 363 | CR2 levels | PROLV000514 | 5.00 | Protein levels | B / plasma cell | 95 | 3 | 9 | 11 | |
| 364 | ALB levels | PROLV000077 | 5.00 | Protein levels | Myeloid | 1,602 | 3 | 15 | 21 | |
| 365 | Menopausal disorder | REPRO000020 | 4.98 | Reproductive | Hepatocyte | 0 | 5 | 9 | 25 | |
| 366 | Female genital tract polyp | REPRO000009 | 4.98 | Reproductive | Stromal / connective | 2 | 3 | 18 | 49 | |
| 367 | POSTN levels | PROLV001603 | 4.95 | Protein levels | Adipose | 40 | 1 | 5 | 14 | |
| 368 | External ear disorder | AUDIO000001 | 4.94 | Auditory | Hepatocyte | 0 | 2 | 8 | 19 | |
| 369 | EGF/TNFSF14 ratio | PRORT000999 | 4.93 | Protein ratios | Hepatocyte | 12 | 4 | 17 | 36 | |
| 370 | BAMBI levels | PROLV000177 | 4.91 | Protein levels | Stromal / connective | 10 | 0 | 1 | 10 | |
| 371 | CCDC80/CHRDL1 ratio | PRORT000333 | 4.91 | Protein ratios | Vascular | 10 | 1 | 5 | 15 | |
| 372 | COL3A1 levels | PROLV000489 | 4.88 | Protein levels | Myeloid | 15 | 4 | 10 | 22 | |
| 373 | NPY/SMOC1 ratio | PRORT001596 | 4.87 | Protein ratios | Hepatocyte | 49 | 2 | 8 | 14 | |
| 374 | OMD levels | PROLV001468 | 4.86 | Protein levels | Myeloid | 95 | 4 | 7 | 13 | |
| 375 | AARSD1/UBAC1 ratio | PRORT000002 | 4.86 | Protein ratios | Muscle / cardiac | 0 | 3 | 6 | 13 | |
| 376 | Alport syndrome | NEPHR000003 | 4.86 | Nephrourologic | Lymphocyte | 3 | 3 | 4 | 20 | |
| 377 | CD74/LILRB4 ratio | PRORT000505 | 4.86 | Protein ratios | Vascular | 42 | 4 | 9 | 21 | |
| 378 | ADGRE5/NOTCH1 ratio | PRORT000032 | 4.83 | Protein ratios | Myeloid | 54 | 3 | 13 | 15 | |
| 379 | PCDH7 levels | PROLV001507 | 4.83 | Protein levels | Neural / glial | 6 | 2 | 9 | 16 | |
| 380 | CA1/TGM2 ratio | PRORT000270 | 4.82 | Protein ratios | Hematopoietic progenitor | 1 | 6 | 9 | 12 | |
| 381 | Cardiac implants and grafts | CARDI000048 | 4.82 | Cardiac | Vascular | 36 | 4 | 9 | 23 | |
| 382 | TP53I3 levels | PROLV002091 | 4.82 | Protein levels | Lymphocyte | 4 | 3 | 12 | 38 | |
| 383 | PARK7/TNFRSF9 ratio | PRORT001621 | 4.81 | Protein ratios | Neural / glial | 8 | 3 | 6 | 18 | |
| 384 | Body fat percentage, hormone-adjusted | BCOMP000001 | 4.79 | Body composition | Hepatocyte | 237 | 2 | 6 | 9 | |
| 385 | DBH levels | PROLV000596 | 4.78 | Protein levels | Myeloid | 48 | 2 | 8 | 16 | |
| 386 | SUSD2 levels | PROLV001979 | 4.76 | Protein levels | B / plasma cell | 15 | 3 | 8 | 14 | |
| 387 | GBP2 levels | PROLV000861 | 4.76 | Protein levels | Myeloid | 0 | 2 | 11 | 16 | |
| 388 | GLB1/IMPA1 ratio | PRORT001216 | 4.74 | Protein ratios | Myeloid | 65 | 4 | 11 | 19 | |
| 389 | IGFBP4/OGN ratio | PRORT001335 | 4.68 | Protein ratios | Stromal / connective | 0 | 2 | 11 | 29 | |
| 390 | Low hand grip strength | MSKEL000032 | 4.68 | Musculoskeletal | Muscle / cardiac | 1 | 4 | 10 | 21 | |
| 391 | Tuberculosis, TB | IMMUN000050 | 4.67 | Immunologic | Muscle / cardiac | — | 3 | 8 | 12 | |
| 392 | Endometriosis | REPRO000005 | 4.67 | Reproductive | Stromal / connective | 49 | 1 | 4 | 8 | |
| 393 | CA2/TGM2 ratio | PRORT000278 | 4.66 | Protein ratios | Epithelial | 17 | 3 | 7 | 15 | |
| 394 | DAB2/TBL1X ratio | PRORT000841 | 4.66 | Protein ratios | Granulosa cell | 1 | 5 | 12 | 35 | |
| 395 | PATE4 levels | PROLV001498 | 4.65 | Protein levels | Muscle / cardiac | 0 | 2 | 9 | 19 | |
| 396 | WIF1 levels | PROLV002193 | 4.65 | Protein levels | Vascular | 116 | 2 | 7 | 15 | |
| 397 | EPCAM levels | PROLV000715 | 4.65 | Protein levels | Vascular | 30 | 1 | 7 | 12 | |
| 398 | FST/FSTL3 ratio | PRORT001180 | 4.64 | Protein ratios | Stromal / connective | 0 | 4 | 15 | 20 | |
| 399 | Ocular motility and refraction disorder | OPHTH000024 | 4.63 | Ophthalmic | Adipose | 7 | 3 | 5 | 12 | |
| 400 | TXN levels | PROLV002123 | 4.63 | Protein levels | Lymphocyte | 1 | 3 | 11 | 28 | |
| 401 | ALCAM/ENPP2 ratio | PRORT000070 | 4.62 | Protein ratios | Hepatocyte | 51 | 3 | 12 | 18 | |
| 402 | Hearing loss, conductive | AUDIO000007 | 4.62 | Auditory | Stromal / connective | 3 | 1 | 7 | 10 | |
| 403 | Synovium, tendon and bursa disorder | MSKEL000057 | 4.62 | Musculoskeletal | Stromal / connective | 1 | 2 | 4 | 7 | |
| 404 | RBP2 levels | PROLV001711 | 4.62 | Protein levels | Neural / glial | 30 | 1 | 10 | 15 | |
| 405 | SMOC2 levels | PROLV001900 | 4.61 | Protein levels | Stromal / connective | 4 | 0 | 1 | 2 | |
| 406 | PSAP levels | PROLV001653 | 4.60 | Protein levels | Myeloid | 52 | 2 | 7 | 16 | |
| 407 | BCAM/CDH5 ratio | PRORT000206 | 4.59 | Protein ratios | Vascular | 42 | 1 | 12 | 12 | |
| 408 | Arterial stiffness | VASCU000050 | 4.59 | Vascular | Stromal / connective | 3 | 2 | 3 | 12 | |
| 409 | MFAP4 levels | PROLV001305 | 4.57 | Protein levels | Myeloid | 75 | 4 | 9 | 20 | |
| 410 | Cerebrovascular disease | VASCU000013 | 4.57 | Vascular | Vascular | 56 | 2 | 6 | 9 | |
| 411 | CHL1 levels | PROLV000430 | 4.57 | Protein levels | Hepatocyte | 10 | 3 | 6 | 15 | |
| 412 | LCN2/S100A12 ratio | PRORT001444 | 4.56 | Protein ratios | Myeloid | 28 | 4 | 18 | 35 | |
| 413 | HEG1 levels | PROLV000961 | 4.56 | Protein levels | Vascular | 51 | 3 | 7 | 16 | |
| 414 | MOG/RTBDN ratio | PRORT001552 | 4.56 | Protein ratios | Stromal / connective | 4 | 2 | 8 | 21 | |
| 415 | APP/CD40LG ratio | PRORT000122 | 4.55 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 13 | 32 | |
| 416 | APP/FKBP1B ratio | PRORT000125 | 4.53 | Protein ratios | Myeloid | 0 | 4 | 15 | 21 | |
| 417 | NCS1/NPY ratio | PRORT001576 | 4.53 | Protein ratios | Hepatocyte | 58 | 2 | 7 | 15 | |
| 418 | Phenylalanine | METAB000027 | 4.52 | Metabolites | Hepatocyte | 104 | 1 | 4 | 10 | |
| 419 | GPHA2 levels | PROLV000922 | 4.51 | Protein levels | Stromal / connective | 9 | 0 | 2 | 3 | |
| 420 | ADAMTS8/FAP ratio | PRORT000026 | 4.51 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 7 | |
| 421 | GFRAL levels | PROLV000879 | 4.51 | Protein levels | Vascular | 26 | 2 | 9 | 20 | |
| 422 | Brain neuroimaging quality metric | NIMAG000006 | 4.49 | Neuroimaging | Muscle / cardiac | 29 | 1 | 2 | 6 | |
| 423 | ERN1 levels | PROLV000730 | 4.49 | Protein levels | Hepatocyte | 95 | 3 | 8 | 18 | |
| 424 | CCL8 levels | PROLV000300 | 4.48 | Protein levels | Myeloid | 76 | 2 | 6 | 14 | |
| 425 | EPS8L2 levels | PROLV000723 | 4.48 | Protein levels | Stromal / connective | 20 | 0 | 10 | 20 | |
| 426 | BCAN/NPTXR ratio | PRORT000219 | 4.48 | Protein ratios | Stromal / connective | 9 | 1 | 6 | 7 | |
| 427 | CCL22/TIMP3 ratio | PRORT000352 | 4.46 | Protein ratios | Vascular | 5 | 2 | 7 | 19 | |
| 428 | IL17D levels | PROLV001052 | 4.45 | Protein levels | Hepatocyte | 18 | 4 | 8 | 25 | |
| 429 | Fatty acids metabolites | METAB000052 | 4.44 | Metabolites | Hepatocyte | 20 | 2 | 4 | 18 | |
| 430 | CD38/RELT ratio | PRORT000440 | 4.43 | Protein ratios | Muscle / cardiac | 2 | 2 | 9 | 17 | |
| 431 | NAAA levels | PROLV001369 | 4.42 | Protein levels | Hepatocyte | 124 | 1 | 5 | 11 | |
| 432 | ADAM9 levels | PROLV000030 | 4.42 | Protein levels | Myeloid | 119 | 3 | 12 | 18 | |
| 433 | Ganglion cell inner plexiform layer thickness | OPHTH000027 | 4.41 | Ophthalmic | Renal epithelium | 10 | 0 | 6 | 5 | |
| 434 | FKBP5/TBCC ratio | PRORT001159 | 4.41 | Protein ratios | Hepatocyte | 10 | 1 | 8 | 14 | |
| 435 | PDGFB/SPARC ratio | PRORT001645 | 4.38 | Protein ratios | Granulosa cell | 9 | 4 | 11 | 31 | |
| 436 | PI16 levels | PROLV001553 | 4.37 | Protein levels | Myeloid | 144 | 1 | 6 | 16 | |
| 437 | Blood pressure, BP, systolic | VASCU000011 | 4.35 | Vascular | Vascular | 1,562 | 4 | 7 | 13 | |
| 438 | CAPG levels | PROLV000262 | 4.35 | Protein levels | Lymphocyte | 34 | 3 | 16 | 42 | |
| 439 | Urinary metabolite ratio | METAB000057 | 4.35 | Metabolites | Hepatocyte | 1 | 1 | 4 | 17 | |
| 440 | IFIT3 levels | PROLV001017 | 4.32 | Protein levels | Stromal / connective | 0 | 2 | 5 | 12 | |
| 441 | FOXJ3 levels | PROLV000825 | 4.31 | Protein levels | Stromal / connective | 0 | 5 | 9 | 28 | |
| 442 | CCN3 levels | PROLV000303 | 4.30 | Protein levels | Vascular | 8 | 1 | 4 | 10 | |
| 443 | MEGF9 levels | PROLV001294 | 4.29 | Protein levels | Hepatocyte | 93 | 2 | 11 | 23 | |
| 444 | MAVS/PPP1R9B ratio | PRORT001498 | 4.28 | Protein ratios | Adipose | 0 | 3 | 12 | 33 | |
| 445 | GRAP2/SNX9 ratio | PRORT001245 | 4.28 | Protein ratios | Hepatocyte | 6 | 4 | 7 | 27 | |
| 446 | NPY levels | PROLV001429 | 4.28 | Protein levels | Hepatocyte | 131 | 2 | 6 | 21 | |
| 447 | GFRA3 levels | PROLV000878 | 4.28 | Protein levels | Myeloid | 91 | 1 | 8 | 21 | |
| 448 | NCR3 levels | PROLV001383 | 4.28 | Protein levels | Adipose | — | 3 | 10 | 28 | |
| 449 | IGFBP6/PTGDS ratio | PRORT001337 | 4.27 | Protein ratios | Myeloid | 19 | 2 | 7 | 18 | |
| 450 | C3 levels | PROLV000232 | 4.27 | Protein levels | Myeloid | 55 | 2 | 6 | 14 | |
| 451 | HSPB6 levels | PROLV000998 | 4.26 | Protein levels | Muscle / cardiac | 7 | 4 | 10 | 26 | |
| 452 | MMP3 levels | PROLV001325 | 4.25 | Protein levels | Myeloid | 51 | 1 | 6 | 8 | |
| 453 | Chronic viral hepatitis | IMMUN000056 | 4.24 | Immunologic | Stromal / connective | 4 | 0 | 1 | 7 | |
| 454 | Acquired absence of organs | MISCL000027 | 4.24 | Miscellaneous | Neural / glial | 1 | 4 | 12 | 15 | |
| 455 | CCN3/COL6A3 ratio | PRORT000372 | 4.24 | Protein ratios | Stromal / connective | 26 | 0 | 3 | 5 | |
| 456 | ADGRG2 levels | PROLV000047 | 4.23 | Protein levels | Myeloid | 24 | 2 | 8 | 15 | |
| 457 | LILRB4 levels | PROLV001215 | 4.21 | Protein levels | Myeloid | 162 | 2 | 8 | 19 | |
| 458 | ROBO1/SPON1 ratio | PRORT001744 | 4.21 | Protein ratios | Vascular | 3 | 3 | 7 | 12 | |
| 459 | RGMB/SMOC2 ratio | PRORT001737 | 4.21 | Protein ratios | Myeloid | 30 | 4 | 10 | 19 | |
| 460 | TSPAN8 levels | PROLV002116 | 4.19 | Protein levels | Hepatocyte | 56 | 1 | 9 | 15 | |
| 461 | Sexually transmitted infection | IMMUN000072 | 4.19 | Immunologic | Granulosa cell | 7 | 4 | 9 | 30 | |
| 462 | FKBPL levels | PROLV000812 | 4.18 | Protein levels | Vascular | 10 | 1 | 6 | 12 | |
| 463 | CPXM2 levels | PROLV000512 | 4.17 | Protein levels | Muscle / cardiac | 0 | 2 | 4 | 14 | |
| 464 | BIRC2/CD40LG ratio | PRORT000235 | 4.17 | Protein ratios | Hepatocyte | 0 | 3 | 10 | 29 | |
| 465 | GGCT levels | PROLV000881 | 4.15 | Protein levels | Lymphocyte | 3 | 4 | 9 | 32 | |
| 466 | SSC5D levels | PROLV001948 | 4.15 | Protein levels | Vascular | 40 | 3 | 14 | 12 | |
| 467 | Hydrocephalus | NEURO000002 | 4.12 | Neurologic | Stromal / connective | 10 | 2 | 4 | 16 | |
| 468 | SMOC1 levels | PROLV001899 | 4.11 | Protein levels | Hepatocyte | 129 | 1 | 6 | 15 | |
| 469 | F7/VASN ratio | PRORT001089 | 4.10 | Protein ratios | Hepatocyte | 19 | 1 | 9 | 12 | |
| 470 | PTPRN2/RTBDN ratio | PRORT001724 | 4.10 | Protein ratios | Neural / glial | 7 | 2 | 6 | 18 | |
| 471 | THBS4 levels | PROLV002027 | 4.09 | Protein levels | Hepatocyte | 69 | 2 | 8 | 18 | |
| 472 | DNER levels | PROLV000637 | 4.09 | Protein levels | Vascular | 69 | 1 | 6 | 18 | |
| 473 | Biventricular shape | CARDI000010 | 4.08 | Cardiac | Muscle / cardiac | 44 | 2 | 4 | 12 | |
| 474 | Intervertebral disc disorder | MSKEL000076 | 4.08 | Musculoskeletal | Stromal / connective | 31 | 2 | 6 | 23 | |
| 475 | CD93 levels | PROLV000362 | 4.07 | Protein levels | Granulosa cell | 47 | 1 | 5 | 10 | |
| 476 | Retinal disorder | OPHTH000040 | 4.07 | Ophthalmic | Hepatocyte | 88 | 0 | 2 | 3 | |
| 477 | Sex-differentiated cardiometabolic traits | MISCL000002 | 4.06 | Miscellaneous | Hepatocyte | 733 | 1 | 9 | 15 | |
| 478 | FABP2/RBP2 ratio | PRORT001099 | 4.04 | Protein ratios | Neural / glial | 2 | 4 | 14 | 20 | |
| 479 | CLEC14A/PIK3IP1 ratio | PRORT000627 | 4.04 | Protein ratios | Vascular | 6 | 2 | 9 | 14 | |
| 480 | CA6 levels | PROLV000247 | 4.02 | Protein levels | Myeloid | 51 | 2 | 14 | 21 | |
| 481 | Dorsopathy | MSKEL000075 | 4.02 | Musculoskeletal | Stromal / connective | 14 | 2 | 7 | 22 | |
| 482 | CD27/FCRL5 ratio | PRORT000413 | 4.01 | Protein ratios | Neural / glial | 71 | 6 | 14 | 27 | |
| 483 | SNX9/STIP1 ratio | PRORT001801 | 4.01 | Protein ratios | Vascular | 0 | 6 | 15 | 31 | |
| 484 | CKAP2 levels | PROLV000438 | 3.97 | Protein levels | Neural / glial | 1 | 4 | 7 | 19 | |
| 485 | GGH/INHBC ratio | PRORT001212 | 3.96 | Protein ratios | Hepatocyte | 39 | 2 | 10 | 25 | |
| 486 | Optic disc morphology | OPHTH000030 | 3.96 | Ophthalmic | Vascular | 8 | 1 | 10 | 15 | |
| 487 | NOTCH3/PTPRS ratio | PRORT001593 | 3.96 | Protein ratios | Vascular | 59 | 5 | 14 | 26 | |
| 488 | GAPDH levels | PROLV000853 | 3.94 | Protein levels | Muscle / cardiac | 0 | 3 | 9 | 33 | |
| 489 | Nucleoside metabolites | METAB000061 | 3.94 | Metabolites | Vascular | 0 | 0 | 1 | 2 | |
| 490 | CLMP/TGFBR2 ratio | PRORT000670 | 3.92 | Protein ratios | Adipose | 11 | 2 | 6 | 6 | |
| 491 | RAD23B levels | PROLV001703 | 3.92 | Protein levels | Stromal / connective | 1 | 4 | 9 | 14 | |
| 492 | LAG3/VCAM1 ratio | PRORT001418 | 3.92 | Protein ratios | Hepatocyte | 24 | 4 | 13 | 36 | |
| 493 | CST3/EFEMP1 ratio | PRORT000782 | 3.91 | Protein ratios | Hepatocyte | 26 | 1 | 6 | 15 | |
| 494 | FURIN/IGSF3 ratio | PRORT001183 | 3.90 | Protein ratios | Hepatocyte | 11 | 1 | 8 | 15 | |
| 495 | Retinal vascular disorder | OPHTH000044 | 3.90 | Ophthalmic | Vascular | 0 | 1 | 6 | 13 | |
| 496 | ACVRL1/SCARB2 ratio | PRORT000015 | 3.88 | Protein ratios | Myeloid | 46 | 2 | 9 | 18 | |
| 497 | Pulmonary nodule | RESPI000018 | 3.88 | Respiratory | Lymphocyte | 2 | 3 | 19 | 36 | |
| 498 | DNAJC9 levels | PROLV000636 | 3.87 | Protein levels | Muscle / cardiac | 1 | 2 | 11 | 35 | |
| 499 | HLA-E levels | PROLV000976 | 3.86 | Protein levels | Stromal / connective | 104 | 1 | 7 | 30 | |
| 500 | AZU1/MPO ratio | PRORT000185 | 3.86 | Protein ratios | Myeloid | 8 | 1 | 4 | 8 | |
| 501 | Myocardial infarction | CARDI000042 | 3.86 | Cardiac | Vascular | 343 | 3 | 9 | 12 | |
| 502 | GZMA/TNFRSF8 ratio | PRORT001262 | 3.85 | Protein ratios | Lymphocyte | 48 | 4 | 14 | 44 | |
| 503 | FCRL2/LY9 ratio | PRORT001130 | 3.83 | Protein ratios | B / plasma cell | 27 | 2 | 8 | 38 | |
| 504 | COL1A1 levels | PROLV000485 | 3.83 | Protein levels | B / plasma cell | 22 | 0 | 1 | 0 | |
| 505 | HPGDS/ITGAV ratio | PRORT001300 | 3.82 | Protein ratios | Hepatocyte | 10 | 3 | 11 | 27 | |
| 506 | CD40LG/SERPINE1 ratio | PRORT000453 | 3.81 | Protein ratios | Hematopoietic progenitor | 2 | 2 | 9 | 18 | |
| 507 | Infertility | REPRO000010 | 3.81 | Reproductive | Vascular | 0 | 0 | 2 | 9 | |
| 508 | FABP5 levels | PROLV000755 | 3.81 | Protein levels | Stromal / connective | 7 | 5 | 11 | 35 | |
| 509 | LTBR levels | PROLV001244 | 3.80 | Protein levels | Hepatocyte | 115 | 1 | 6 | 17 | |
| 510 | Muscle fat infiltration | BCOMP000011 | 3.79 | Body composition | Myeloid | 40 | 2 | 8 | 20 | |
| 511 | Total protein levels | PROLV002131 | 3.77 | Protein levels | Myeloid | 897 | 4 | 12 | 26 | |
| 512 | LRRN1 levels | PROLV001236 | 3.77 | Protein levels | Muscle / cardiac | 81 | 3 | 8 | 25 | |
| 513 | PPP2R2A levels | PROLV001618 | 3.75 | Protein levels | Lymphocyte | 0 | 3 | 9 | 29 | |
| 514 | GABARAPL1 levels | PROLV000844 | 3.75 | Protein levels | Hepatocyte | — | 2 | 8 | 14 | |
| 515 | Mononeuropathy | NEURO000027 | 3.74 | Neurologic | Stromal / connective | 2 | 0 | 0 | 3 | |
| 516 | FSTL3/SPON2 ratio | PRORT001182 | 3.73 | Protein ratios | Hepatocyte | 3 | 2 | 9 | 23 | |
| 517 | CLSTN2/MATN2 ratio | PRORT000676 | 3.73 | Protein ratios | Hepatocyte | 25 | 2 | 8 | 16 | |
| 518 | Weight, birth | BMORP000018 | 3.72 | Body morphology | Vascular | 117 | 2 | 6 | 16 | |
| 519 | ALCAM/MSR1 ratio | PRORT000074 | 3.72 | Protein ratios | Myeloid | 30 | 2 | 10 | 13 | |
| 520 | Medication, angiotensin receptor blocker | VASCU000029 | 3.69 | Vascular | Adipose | 0 | 1 | 8 | 19 | |
| 521 | Retinal vascular morphology | OPHTH000045 | 3.67 | Ophthalmic | Vascular | 253 | 2 | 5 | 7 | |
| 522 | Benign neoplasm, Endocrine | MALIG000003 | 3.66 | Malignancy | Myeloid | 1 | 3 | 9 | 18 | |
| 523 | ITGA2 levels | PROLV001105 | 3.66 | Protein levels | Vascular | 76 | 3 | 13 | 27 | |
| 524 | Osteomyelitis | IMMUN000068 | 3.66 | Immunologic | Stromal / connective | 19 | 2 | 4 | 5 | |
| 525 | BGLAP levels | PROLV000193 | 3.66 | Protein levels | Stromal / connective | 19 | 3 | 7 | 17 | |
| 526 | SERPING1 levels | PROLV001834 | 3.65 | Protein levels | Myeloid | 141 | 3 | 12 | 23 | |
| 527 | FURIN/PLA2G15 ratio | PRORT001185 | 3.64 | Protein ratios | Adipose | 9 | 2 | 8 | 18 | |
| 528 | FAM3B levels | PROLV000766 | 3.64 | Protein levels | Gastrointestinal epithelium | 66 | 0 | 6 | 7 | |
| 529 | JAM2/RGMB ratio | PRORT001396 | 3.63 | Protein ratios | Vascular | 2 | 2 | 6 | 11 | |
| 530 | SOST levels | PROLV001922 | 3.63 | Protein levels | Myeloid | 33 | 1 | 5 | 9 | |
| 531 | Arthropathy | MSKEL000013 | 3.61 | Musculoskeletal | Stromal / connective | 24 | 4 | 6 | 20 | |
| 532 | Mental disorder | PSYCH000013 | 3.61 | Psychiatric | Neural / glial | 21 | 2 | 9 | 20 | |
| 533 | APOA4 levels | PROLV000119 | 3.60 | Protein levels | Granulosa cell | 12 | 0 | 5 | 7 | |
| 534 | FGFR2 levels | PROLV000801 | 3.59 | Protein levels | Adipose | 45 | 0 | 5 | 11 | |
| 535 | CCL11/CCL2 ratio | PRORT000335 | 3.57 | Protein ratios | Muscle / cardiac | 13 | 2 | 5 | 11 | |
| 536 | MCEE levels | PROLV001284 | 3.56 | Protein levels | Myeloid | 2 | 3 | 11 | 27 | |
| 537 | Vitamin E | METAB000079 | 3.56 | Metabolites | Hepatocyte | 2 | 1 | 5 | 12 | |
| 538 | IGBP1 levels | PROLV001023 | 3.56 | Protein levels | Lymphocyte | 1 | 3 | 12 | 33 | |
| 539 | B4GALT1/SMOC2 ratio | PRORT000189 | 3.55 | Protein ratios | Myeloid | 7 | 2 | 6 | 18 | |
| 540 | CD4/LILRB4 ratio | PRORT000441 | 3.55 | Protein ratios | Myeloid | 61 | 4 | 11 | 12 | |
| 541 | CD200 levels | PROLV000316 | 3.54 | Protein levels | Adipose | 41 | 1 | 7 | 7 | |
| 542 | PFDN5 levels | PROLV001539 | 3.54 | Protein levels | Muscle / cardiac | 0 | 4 | 9 | 24 | |
| 543 | Cataract | OPHTH000012 | 3.54 | Ophthalmic | Vascular | 103 | 0 | 4 | 9 | |
| 544 | Coagulation disorder | HEMAT000017 | 3.53 | Hematologic | Stromal / connective | 25 | 1 | 3 | 10 | |
| 545 | SCAMP3/VPS53 ratio | PRORT001757 | 3.52 | Protein ratios | Vascular | 0 | 2 | 9 | 19 | |
| 546 | Operation, respiratory | RESPI000025 | 3.51 | Respiratory | Vascular | 61 | 3 | 12 | 22 | |
| 547 | PGLS levels | PROLV001545 | 3.51 | Protein levels | Neural / glial | 0 | 5 | 6 | 27 | |
| 548 | SLC9A3R2 levels | PROLV001886 | 3.51 | Protein levels | Vascular | 16 | 2 | 7 | 14 | |
| 549 | GPNMB levels | PROLV000927 | 3.51 | Protein levels | Hepatocyte | 49 | 5 | 9 | 24 | |
| 550 | PTPRH levels | PROLV001676 | 3.50 | Protein levels | Vascular | 69 | 3 | 7 | 15 | |
| 551 | CLEC1B/MGLL ratio | PRORT000643 | 3.49 | Protein ratios | Vascular | 24 | 6 | 14 | 30 | |
| 552 | Enamel hypoplasia | DENTA000002 | 3.48 | Dental | Vascular | 0 | 0 | 13 | 48 | |
| 553 | Free androgen index | ENDOC000007 | 3.48 | Endocrine | Hepatocyte | 616 | 1 | 6 | 20 | |
| 554 | APEX1/LSP1 ratio | PRORT000116 | 3.47 | Protein ratios | Myeloid | 14 | 4 | 9 | 14 | |
| 555 | DCN levels | PROLV000601 | 3.45 | Protein levels | Myeloid | 65 | 3 | 10 | 14 | |
| 556 | Impacted cerumen | AUDIO000002 | 3.45 | Auditory | Salivary epithelium | 1 | 1 | 8 | 14 | |
| 557 | PITHD1 levels | PROLV001563 | 3.45 | Protein levels | Vascular | 0 | 1 | 6 | 10 | |
| 558 | Stroke | VASCU000017 | 3.44 | Vascular | Vascular | 37 | 2 | 4 | 11 | |
| 559 | ICAM2 levels | PROLV001005 | 3.44 | Protein levels | Vascular | 38 | 4 | 7 | 20 | |
| 560 | EFEMP1/IL18BP ratio | PRORT000987 | 3.44 | Protein ratios | Stromal / connective | 1 | 1 | 6 | 16 | |
| 561 | FCRL2/KLB ratio | PRORT001129 | 3.44 | Protein ratios | Hepatocyte | 35 | 1 | 5 | 11 | |
| 562 | CLUL1 levels | PROLV000468 | 3.41 | Protein levels | Hepatocyte | 71 | 4 | 9 | 27 | |
| 563 | Jaw relationship anomaly | DENTA000007 | 3.41 | Dental | Neural / glial | 0 | 1 | 5 | 12 | |
| 564 | Nerve root disorder | NEURO000030 | 3.41 | Neurologic | Stromal / connective | 3 | 2 | 5 | 15 | |
| 565 | PINLYP levels | PROLV001562 | 3.40 | Protein levels | Myeloid | 66 | 4 | 10 | 14 | |
| 566 | DCBLD2 levels | PROLV000600 | 3.40 | Protein levels | Hepatocyte | 264 | 3 | 13 | 20 | |
| 567 | CDHR2 levels | PROLV000379 | 3.40 | Protein levels | Hepatocyte | 103 | 2 | 13 | 22 | |
| 568 | Blood pressure, BP, diastolic | VASCU000009 | 3.40 | Vascular | Vascular | 1,488 | 3 | 6 | 10 | |
| 569 | SSH3 levels | PROLV001949 | 3.40 | Protein levels | Stromal / connective | — | 1 | 10 | 6 | |
| 570 | Liver volume | HPBIL000025 | 3.39 | Hepatopancreatobiliary | Myeloid | 26 | 4 | 13 | 12 | |
| 571 | Eye disorder, none | OPHTH000007 | 3.39 | Ophthalmic | Neural / glial | — | 4 | 14 | 11 | |
| 572 | ACVRL1/TNFRSF9 ratio | PRORT000018 | 3.39 | Protein ratios | Myeloid | 12 | 2 | 11 | 19 | |
| 573 | FABP2 levels | PROLV000752 | 3.36 | Protein levels | Myeloid | 44 | 4 | 10 | 17 | |
| 574 | Peripheral artery disease | VASCU000042 | 3.34 | Vascular | Vascular | 44 | 3 | 9 | 23 | |
| 575 | CD27/TNFRSF9 ratio | PRORT000419 | 3.33 | Protein ratios | B / plasma cell | 20 | 5 | 15 | 40 | |
| 576 | CCL13/CCL17 ratio | PRORT000337 | 3.32 | Protein ratios | Myeloid | 17 | 3 | 8 | 27 | |
| 577 | HRC levels | PROLV000987 | 3.31 | Protein levels | Stromal / connective | 43 | 5 | 12 | 32 | |
| 578 | CPM levels | PROLV000507 | 3.29 | Protein levels | Myeloid | 138 | 3 | 11 | 11 | |
| 579 | CA2/UBAC1 ratio | PRORT000279 | 3.29 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 10 | |
| 580 | HNRNPUL1 levels | PROLV000983 | 3.29 | Protein levels | Lymphocyte | 15 | 4 | 11 | 41 | |
| 581 | FGF5 levels | PROLV000797 | 3.29 | Protein levels | Hepatocyte | 31 | 3 | 5 | 10 | |
| 582 | FCRL2/SEMA7A ratio | PRORT001131 | 3.28 | Protein ratios | B / plasma cell | 15 | 1 | 8 | 26 | |
| 583 | ARF6 levels | PROLV000133 | 3.28 | Protein levels | Stromal / connective | 50 | 5 | 15 | 21 | |
| 584 | GSTT2 levels | PROLV000942 | 3.28 | Protein levels | Gastrointestinal epithelium | 0 | 0 | 7 | 8 | |
| 585 | CLMP/GFRA1 ratio | PRORT000668 | 3.27 | Protein ratios | Hepatocyte | 49 | 2 | 9 | 18 | |
| 586 | Ischaemic heart disease | CARDI000041 | 3.26 | Cardiac | Vascular | 595 | 3 | 10 | 19 | |
| 587 | Brain ventricle volume | NIMAG000016 | 3.25 | Neuroimaging | Stromal / connective | 27 | 1 | 2 | 13 | |
| 588 | CD69/CDKN2D ratio | PRORT000487 | 3.25 | Protein ratios | Vascular | 6 | 3 | 8 | 16 | |
| 589 | Xenobiotic metabolites | METAB000080 | 3.25 | Metabolites | Hepatocyte | 26 | 1 | 3 | 11 | |
| 590 | Bone marrow fat fraction, femur | MSKEL000001 | 3.25 | Musculoskeletal | Adipose | 27 | 3 | 8 | 14 | |
| 591 | Tyrosine metabolites | METAB000016 | 3.25 | Metabolites | Muscle / cardiac | 0 | 2 | 4 | 16 | |
| 592 | CCDC80 levels | PROLV000276 | 3.25 | Protein levels | Myeloid | 30 | 2 | 6 | 14 | |
| 593 | Cancer, Endometrium | MALIG000014 | 3.25 | Malignancy | Lymphocyte | 8 | 2 | 14 | 50 | |
| 594 | Cortical thickness | NIMAG000010 | 3.24 | Neuroimaging | Neural / glial | 39 | 3 | 7 | 20 | |
| 595 | ACAN levels | PROLV000010 | 3.24 | Protein levels | Stromal / connective | 76 | 3 | 7 | 17 | |
| 596 | CERT/MAX ratio | PRORT000605 | 3.23 | Protein ratios | Stromal / connective | 0 | 4 | 12 | 23 | |
| 597 | DPP6 levels | PROLV000647 | 3.23 | Protein levels | Myeloid | 131 | 3 | 11 | 15 | |
| 598 | CD302 levels | PROLV000334 | 3.23 | Protein levels | Myeloid | 157 | 1 | 13 | 19 | |
| 599 | SEZ6L2 levels | PROLV001842 | 3.22 | Protein levels | Myeloid | 148 | 2 | 6 | 12 | |
| 600 | AXL levels | PROLV000167 | 3.22 | Protein levels | Myeloid | 83 | 4 | 14 | 44 | |
| 601 | Frailty, multimorbidity | METBL000012 | 3.21 | Metabolic | Vascular | 188 | 3 | 10 | 10 | |
| 602 | GDNF levels | PROLV000872 | 3.20 | Protein levels | Muscle / cardiac | 3 | 3 | 3 | 13 | |
| 603 | ALPI levels | PROLV000082 | 3.20 | Protein levels | Stromal / connective | 4 | 0 | 4 | 21 | |
| 604 | Cancer, Pancreas | MALIG000025 | 3.20 | Malignancy | Myeloid | 0 | 0 | 5 | 4 | |
| 605 | Hydrocele | REPRO000012 | 3.17 | Reproductive | Stromal / connective | 7 | 0 | 8 | 15 | |
| 606 | CTSC/PLA2G15 ratio | PRORT000798 | 3.16 | Protein ratios | Hepatocyte | 20 | 1 | 10 | 34 | |
| 607 | CD58/MEGF10 ratio | PRORT000477 | 3.14 | Protein ratios | Muscle / cardiac | 15 | 5 | 19 | 37 | |
| 608 | AHNAK2 levels | PROLV000063 | 3.14 | Protein levels | Adipose | 19 | 0 | 2 | 13 | |
| 609 | CIAPIN1/SPARC ratio | PRORT000618 | 3.13 | Protein ratios | Myeloid | 9 | 1 | 8 | 13 | |
| 610 | CD48 levels | PROLV000343 | 3.13 | Protein levels | B / plasma cell | 92 | 2 | 8 | 19 | |
| 611 | MPO levels | PROLV001336 | 3.13 | Protein levels | Myeloid | 55 | 2 | 5 | 10 | |
| 612 | EBV EA-D antibody | IMMUN000060 | 3.12 | Immunologic | Muscle / cardiac | 8 | 1 | 5 | 13 | |
| 613 | Blood pressure, BP, diastolic x sex interaction | VASCU000008 | 3.12 | Vascular | Muscle / cardiac | 0 | 2 | 12 | 23 | |
| 614 | Glutamate metabolites | METAB000005 | 3.11 | Metabolites | Vascular | 0 | 0 | 2 | 5 | |
| 615 | Varicose veins, VV | VASCU000061 | 3.11 | Vascular | Vascular | 132 | 1 | 4 | 11 | |
| 616 | AHCY/FABP5 ratio | PRORT000054 | 3.11 | Protein ratios | Muscle / cardiac | 0 | 1 | 8 | 14 | |
| 617 | ATXN10/SLC27A4 ratio | PRORT000163 | 3.10 | Protein ratios | Granulosa cell | 0 | 2 | 7 | 13 | |
| 618 | Family medical history, none | MISCL000010 | 3.10 | Miscellaneous | Vascular | 6 | 0 | 0 | 3 | |
| 619 | Osteoarthritis, OA | MSKEL000012 | 3.09 | Musculoskeletal | Stromal / connective | 85 | 1 | 2 | 6 | |
| 620 | NOTCH3 levels | PROLV001418 | 3.08 | Protein levels | Hepatocyte | 166 | 2 | 12 | 29 | |
| 621 | CA5A/KRT18 ratio | PRORT000288 | 3.07 | Protein ratios | Hepatocyte | 18 | 1 | 10 | 19 | |
| 622 | ADAMTSL4 levels | PROLV000037 | 3.07 | Protein levels | Myeloid | 49 | 3 | 12 | 24 | |
| 623 | IDS/SMPDL3A ratio | PRORT001330 | 3.06 | Protein ratios | Hepatocyte | 53 | 2 | 8 | 19 | |
| 624 | Optic disc area | OPHTH000029 | 3.06 | Ophthalmic | Vascular | 11 | 4 | 7 | 13 | |
| 625 | Medication, renin-angiotensin system agent | VASCU000040 | 3.05 | Vascular | Vascular | 24 | 0 | 4 | 8 | |
| 626 | F3 levels | PROLV000746 | 3.05 | Protein levels | Vascular | 50 | 0 | 8 | 7 | |
| 627 | Immune cell marker, CD8 T cell | HEMAT000023 | 3.03 | Hematologic | Lymphocyte | 17 | 2 | 18 | 40 | |
| 628 | BLVRB/CA2 ratio | PRORT000239 | 3.03 | Protein ratios | Vascular | 0 | 0 | 7 | 11 | |
| 629 | Valine | METAB000032 | 3.03 | Metabolites | Hepatocyte | 209 | 2 | 6 | 18 | |
| 630 | Medication, laxative | GASTR000016 | 3.03 | Gastrointestinal | Myeloid | 0 | 2 | 4 | 15 | |
| 631 | MOG/PTPRN2 ratio | PRORT001551 | 3.02 | Protein ratios | Neural / glial | 28 | 3 | 3 | 10 | |
| 632 | Medication, anti-malarial | IMMUN000083 | 3.02 | Immunologic | Neural / glial | 0 | 2 | 6 | 16 | |
| 633 | ESAM/TGFB1 ratio | PRORT001067 | 3.02 | Protein ratios | Muscle / cardiac | 20 | 4 | 11 | 17 | |
| 634 | HSPG2/VASN ratio | PRORT001310 | 3.01 | Protein ratios | Vascular | 16 | 4 | 7 | 21 | |
| 635 | ADAMTSL5 levels | PROLV000038 | 2.99 | Protein levels | Muscle / cardiac | 9 | 4 | 6 | 14 | |
| 636 | Hypertension, secondary | VASCU000026 | 2.99 | Vascular | Renal epithelium | — | 0 | 17 | 26 | |
| 637 | COL6A3/NBL1 ratio | PRORT000698 | 2.99 | Protein ratios | Stromal / connective | 29 | 2 | 2 | 8 | |
| 638 | Isoleucine | METAB000024 | 2.99 | Metabolites | Hepatocyte | 28 | 3 | 6 | 20 | |
| 639 | FSHB levels | PROLV000828 | 2.98 | Protein levels | Myeloid | 0 | 1 | 7 | 14 | |
| 640 | JAM2/TGFBR2 ratio | PRORT001397 | 2.98 | Protein ratios | Adipose | 13 | 0 | 4 | 8 | |
| 641 | CD99/MMP3 ratio | PRORT000535 | 2.98 | Protein ratios | Hepatocyte | 6 | 1 | 7 | 14 | |
| 642 | INHBC levels | PROLV001088 | 2.97 | Protein levels | Hepatocyte | 91 | 2 | 8 | 18 | |
| 643 | NTRK2 levels | PROLV001447 | 2.97 | Protein levels | Myeloid | 73 | 3 | 11 | 21 | |
| 644 | Cortical volume | NIMAG000022 | 2.97 | Neuroimaging | Stromal / connective | 22 | 0 | 0 | 0 | |
| 645 | BTD levels | PROLV000218 | 2.97 | Protein levels | Hepatocyte | 77 | 3 | 11 | 13 | |
| 646 | GPD1 levels | PROLV000921 | 2.97 | Protein levels | Neural / glial | 0 | 3 | 7 | 11 | |
| 647 | CNTN4 levels | PROLV000478 | 2.96 | Protein levels | Myeloid | 28 | 0 | 1 | 5 | |
| 648 | ERBB2/FURIN ratio | PRORT001042 | 2.95 | Protein ratios | Hepatocyte | 39 | 2 | 7 | 17 | |
| 649 | Breast disorder | BREAS000002 | 2.95 | Breast | Respiratory epithelium | 0 | 0 | 11 | 13 | |
| 650 | SNX15 levels | PROLV001911 | 2.95 | Protein levels | Lymphocyte | 12 | 5 | 20 | 50 | |
| 651 | LEPR/NTRK2 ratio | PRORT001448 | 2.94 | Protein ratios | Neural / glial | 24 | 4 | 10 | 21 | |
| 652 | Tonsillar and adenoidal disorders | RESPI000040 | 2.93 | Respiratory | Myeloid | 125 | 2 | 10 | 27 | |
| 653 | EGF/MGLL ratio | PRORT000996 | 2.93 | Protein ratios | Vascular | 11 | 3 | 8 | 27 | |
| 654 | CTHRC1 levels | PROLV000556 | 2.92 | Protein levels | Myeloid | 27 | 4 | 11 | 12 | |
| 655 | LEPR levels | PROLV001200 | 2.92 | Protein levels | Myeloid | 79 | 3 | 10 | 26 | |
| 656 | FUS levels | PROLV000836 | 2.92 | Protein levels | Vascular | 2 | 5 | 11 | 21 | |
| 657 | CCN5/IGFBP6 ratio | PRORT000375 | 2.92 | Protein ratios | Stromal / connective | 6 | 1 | 3 | 18 | |
| 658 | BMP4 levels | PROLV000203 | 2.91 | Protein levels | Granulosa cell | 46 | 2 | 8 | 26 | |
| 659 | Fatty liver disease, nonalcoholic | HPBIL000031 | 2.91 | Hepatopancreatobiliary | Vascular | 19 | 1 | 7 | 16 | |
| 660 | CELSR2 levels | PROLV000398 | 2.90 | Protein levels | Muscle / cardiac | 14 | 2 | 9 | 15 | |
| 661 | ADAMTS13 levels | PROLV000031 | 2.89 | Protein levels | Hepatocyte | 161 | 2 | 10 | 17 | |
| 662 | MIF/SUSD2 ratio | PRORT001535 | 2.89 | Protein ratios | Vascular | 33 | 1 | 7 | 22 | |
| 663 | MDH1 levels | PROLV001289 | 2.89 | Protein levels | Myeloid | 2 | 3 | 9 | 19 | |
| 664 | LTA/LTBR ratio | PRORT001463 | 2.89 | Protein ratios | B / plasma cell | 14 | 1 | 7 | 32 | |
| 665 | Headache | NEURO000009 | 2.88 | Neurologic | Neural / glial | 18 | 1 | 5 | 18 | |
| 666 | CDHR5 levels | PROLV000380 | 2.88 | Protein levels | Hepatocyte | 114 | 1 | 5 | 9 | |
| 667 | ALDH1A1 levels | PROLV000079 | 2.86 | Protein levels | Hepatocyte | 16 | 2 | 9 | 22 | |
| 668 | HEPH levels | PROLV000963 | 2.86 | Protein levels | Lymphocyte | 12 | 0 | 9 | 27 | |
| 669 | CASP8/DDX58 ratio | PRORT000321 | 2.85 | Protein ratios | Myeloid | 2 | 2 | 8 | 11 | |
| 670 | PRKAR1A/SNAP23 ratio | PRORT001710 | 2.85 | Protein ratios | Hepatocyte | 4 | 3 | 18 | 38 | |
| 671 | ECG QRS-T angle | CARDI000033 | 2.85 | Cardiac | Muscle / cardiac | 57 | 2 | 4 | 10 | |
| 672 | DIABLO/PRKAR1A ratio | PRORT000893 | 2.84 | Protein ratios | Myeloid | 12 | 3 | 12 | 18 | |
| 673 | ECG-predicted BMI discrepancy | BMORP000008 | 2.83 | Body morphology | Muscle / cardiac | 0 | 2 | 5 | 20 | |
| 674 | Gut microbial abundance, Olsenella C | GASTR000030 | 2.83 | Gastrointestinal | Vascular | 0 | 4 | 10 | 24 | |
| 675 | CCN3/PGF ratio | PRORT000374 | 2.83 | Protein ratios | Vascular | 2 | 4 | 6 | 28 | |
| 676 | ESAM/LAMA4 ratio | PRORT001063 | 2.82 | Protein ratios | Vascular | 16 | 4 | 9 | 15 | |
| 677 | CD22/CD79B ratio | PRORT000399 | 2.82 | Protein ratios | B / plasma cell | 16 | 1 | 7 | 10 | |
| 678 | PRL levels | PROLV001635 | 2.81 | Protein levels | Lymphocyte | 17 | 2 | 9 | 27 | |
| 679 | MSR1 levels | PROLV001342 | 2.81 | Protein levels | Myeloid | 116 | 3 | 10 | 13 | |
| 680 | SCLY/SORD ratio | PRORT001764 | 2.81 | Protein ratios | Myeloid | 1 | 3 | 10 | 16 | |
| 681 | CIAPIN1/SNX9 ratio | PRORT000617 | 2.81 | Protein ratios | Vascular | 0 | 4 | 15 | 42 | |
| 682 | IFNGR2 levels | PROLV001021 | 2.81 | Protein levels | Myeloid | 122 | 5 | 14 | 30 | |
| 683 | Cortical surface area | NIMAG000009 | 2.80 | Neuroimaging | Neural / glial | 78 | 0 | 0 | 0 | |
| 684 | CA2/HMBS ratio | PRORT000275 | 2.80 | Protein ratios | Lymphocyte | 4 | 1 | 13 | 42 | |
| 685 | MB levels | PROLV001281 | 2.80 | Protein levels | Muscle / cardiac | 26 | 3 | 4 | 11 | |
| 686 | Peripheral vascular disease | VASCU000043 | 2.78 | Vascular | Stromal / connective | 65 | 3 | 6 | 14 | |
| 687 | Abnormal heart sounds | CARDI000051 | 2.77 | Cardiac | Muscle / cardiac | 19 | 4 | 6 | 14 | |
| 688 | CST6 levels | PROLV000551 | 2.77 | Protein levels | Cutaneous epithelium | 33 | 1 | 10 | 10 | |
| 689 | FCGR3B levels | PROLV000780 | 2.76 | Protein levels | Myeloid | 115 | 2 | 9 | 12 | |
| 690 | PON2/PON3 ratio | PRORT001698 | 2.76 | Protein ratios | Hepatocyte | 8 | 2 | 6 | 20 | |
| 691 | PDGFC/TFPI ratio | PRORT001653 | 2.75 | Protein ratios | Hepatocyte | 52 | 2 | 12 | 21 | |
| 692 | CCL22/PDGFB ratio | PRORT000351 | 2.75 | Protein ratios | Hepatocyte | 7 | 3 | 15 | 43 | |
| 693 | Acne | DERMA000028 | 2.74 | Dermatologic | Cutaneous epithelium | 14 | 0 | 8 | 7 | |
| 694 | Ventricular wall thickness | CARDI000016 | 2.72 | Cardiac | Muscle / cardiac | 47 | 2 | 3 | 11 | |
| 695 | FST levels | PROLV000829 | 2.72 | Protein levels | Granulosa cell | 34 | 2 | 6 | 15 | |
| 696 | BSG/LAMP3 ratio | PRORT000248 | 2.71 | Protein ratios | Myeloid | 33 | 1 | 8 | 14 | |
| 697 | MMP10 levels | PROLV001322 | 2.70 | Protein levels | Epithelial | 12 | 0 | 6 | 7 | |
| 698 | GALNT10/IGSF3 ratio | PRORT001201 | 2.70 | Protein ratios | Hepatocyte | 8 | 3 | 11 | 21 | |
| 699 | Heme malignancy, Lymphoma | MALIG000044 | 2.69 | Malignancy | B / plasma cell | 27 | 2 | 6 | 28 | |
| 700 | CCN1/DNAJB1 ratio | PRORT000361 | 2.69 | Protein ratios | Hepatocyte | 26 | 4 | 14 | 37 | |
| 701 | Pre-eclampsia | VASCU000047 | 2.69 | Vascular | Myeloid | 7 | 2 | 3 | 7 | |
| 702 | MEPE levels | PROLV001299 | 2.69 | Protein levels | Muscle / cardiac | 39 | 2 | 7 | 17 | |
| 703 | BAX levels | PROLV000180 | 2.68 | Protein levels | Vascular | 2 | 5 | 7 | 20 | |
| 704 | AAMDC levels | PROLV000004 | 2.68 | Protein levels | Myeloid | 19 | 1 | 5 | 7 | |
| 705 | Family history, coronary artery disease | VASCU000021 | 2.68 | Vascular | Vascular | 26 | 0 | 2 | 7 | |
| 706 | MITD1/SNX9 ratio | PRORT001537 | 2.67 | Protein ratios | Hepatocyte | 2 | 5 | 13 | 26 | |
| 707 | F11R/PARK7 ratio | PRORT001072 | 2.67 | Protein ratios | Hepatocyte | 0 | 1 | 7 | 26 | |
| 708 | SF3B4 levels | PROLV001843 | 2.66 | Protein levels | Myeloid | 8 | 3 | 11 | 20 | |
| 709 | OLR1/PLAUR ratio | PRORT001613 | 2.66 | Protein ratios | Myeloid | 36 | 3 | 7 | 11 | |
| 710 | ADGRE5/VCAM1 ratio | PRORT000034 | 2.66 | Protein ratios | Myeloid | 37 | 4 | 11 | 18 | |
| 711 | Medication, diuretic | VASCU000038 | 2.66 | Vascular | Vascular | 21 | 1 | 5 | 16 | |
| 712 | DAB2/NCK2 ratio | PRORT000840 | 2.65 | Protein ratios | Myeloid | 2 | 3 | 9 | 13 | |
| 713 | Retinal thickness | OPHTH000043 | 2.64 | Ophthalmic | Neural / glial | 58 | 1 | 5 | 7 | |
| 714 | SCARF2/TNFRSF21 ratio | PRORT001763 | 2.64 | Protein ratios | Myeloid | 9 | 5 | 8 | 25 | |
| 715 | Anal and rectal disorder | GASTR000001 | 2.64 | Gastrointestinal | Gastrointestinal epithelium | 1 | 0 | 7 | 4 | |
| 716 | ACVRL1/TNFRSF10B ratio | PRORT000016 | 2.64 | Protein ratios | Myeloid | 40 | 3 | 11 | 16 | |
| 717 | ALCAM/CDH5 ratio | PRORT000068 | 2.63 | Protein ratios | Hepatocyte | 26 | 1 | 8 | 15 | |
| 718 | DPP10 levels | PROLV000645 | 2.63 | Protein levels | Vascular | 10 | 2 | 9 | 19 | |
| 719 | CSF unidentified metabolite | METAB000075 | 2.63 | Metabolites | Muscle / cardiac | 1 | 0 | 2 | 3 | |
| 720 | Benign neoplasm, Colorectal | MALIG000002 | 2.63 | Malignancy | Stromal / connective | 41 | 0 | 4 | 4 | |
| 721 | C1QTNF1/COL4A1 ratio | PRORT000263 | 2.63 | Protein ratios | Granulosa cell | 30 | 2 | 5 | 14 | |
| 722 | LBP levels | PROLV001188 | 2.62 | Protein levels | Hepatocyte | 18 | 2 | 7 | 22 | |
| 723 | CDH5/ENG ratio | PRORT000556 | 2.61 | Protein ratios | Vascular | 30 | 2 | 8 | 14 | |
| 724 | TGFBR2/TNFRSF19 ratio | PRORT001834 | 2.61 | Protein ratios | Neural / glial | 12 | 3 | 7 | 13 | |
| 725 | MANSC1/PODXL ratio | PRORT001483 | 2.61 | Protein ratios | Hepatocyte | 5 | 1 | 8 | 13 | |
| 726 | SMPD1 levels | PROLV001901 | 2.60 | Protein levels | Hepatocyte | 179 | 1 | 7 | 16 | |
| 727 | PTP4A3 levels | PROLV001670 | 2.60 | Protein levels | Myeloid | 2 | 2 | 16 | 21 | |
| 728 | CFB levels | PROLV000410 | 2.60 | Protein levels | Hepatocyte | 101 | 4 | 14 | 24 | |
| 729 | LY6D/PLA2G10 ratio | PRORT001469 | 2.60 | Protein ratios | Vascular | 48 | 3 | 10 | 17 | |
| 730 | ERBIN/TBC1D23 ratio | PRORT001052 | 2.60 | Protein ratios | Hepatocyte | 0 | 4 | 9 | 17 | |
| 731 | CD177 levels | PROLV000314 | 2.59 | Protein levels | Myeloid | 21 | 1 | 6 | 7 | |
| 732 | CDH3/NECTIN4 ratio | PRORT000554 | 2.59 | Protein ratios | Respiratory epithelium | 19 | 0 | 10 | 9 | |
| 733 | CGREF1/FAM3C ratio | PRORT000609 | 2.59 | Protein ratios | Hepatocyte | 2 | 0 | 4 | 8 | |
| 734 | Shift work | SOCIO000008 | 2.58 | Socioeconomic | Granulosa cell | 0 | 1 | 4 | 18 | |
| 735 | SPP1 levels | PROLV001938 | 2.58 | Protein levels | Vascular | 68 | 4 | 9 | 23 | |
| 736 | ANXA4/LACTB2 ratio | PRORT000112 | 2.58 | Protein ratios | Myeloid | 0 | 3 | 7 | 11 | |
| 737 | Ocular alignment procedures | OPHTH000026 | 2.57 | Ophthalmic | Neural / glial | 1 | 2 | 5 | 18 | |
| 738 | Cystatin C | NEPHR000019 | 2.57 | Nephrourologic | Myeloid | 898 | 1 | 7 | 9 | |
| 739 | ENTPD5 levels | PROLV000713 | 2.57 | Protein levels | Myeloid | 111 | 3 | 8 | 15 | |
| 740 | SPARCL1 levels | PROLV001924 | 2.57 | Protein levels | Hepatocyte | 112 | 2 | 9 | 18 | |
| 741 | COL6A3/SPON2 ratio | PRORT000701 | 2.56 | Protein ratios | Neural / glial | 20 | 3 | 6 | 25 | |
| 742 | ADGRE2/B4GALT1 ratio | PRORT000027 | 2.55 | Protein ratios | Myeloid | 57 | 3 | 11 | 23 | |
| 743 | SPINT1 levels | PROLV001932 | 2.55 | Protein levels | Cutaneous epithelium | 74 | 0 | 5 | 11 | |
| 744 | COLEC12/LTBR ratio | PRORT000703 | 2.55 | Protein ratios | Myeloid | 50 | 3 | 7 | 12 | |
| 745 | Medication, antiplatelet | VASCU000032 | 2.55 | Vascular | Vascular | 78 | 1 | 5 | 9 | |
| 746 | Heart rate variability | CARDI000022 | 2.54 | Cardiac | Muscle / cardiac | 10 | 2 | 4 | 15 | |
| 747 | PKLR/UBAC1 ratio | PRORT001669 | 2.54 | Protein ratios | Muscle / cardiac | 11 | 1 | 7 | 8 | |
| 748 | Operation, gastrointestinal | GASTR000039 | 2.54 | Gastrointestinal | Hepatocyte | 208 | 1 | 2 | 11 | |
| 749 | CLEC10A levels | PROLV000444 | 2.53 | Protein levels | Myeloid | 116 | 2 | 8 | 14 | |
| 750 | ITGAM levels | PROLV001109 | 2.53 | Protein levels | Myeloid | 94 | 2 | 11 | 15 | |
| 751 | CBLN4/RET ratio | PRORT000326 | 2.53 | Protein ratios | Vascular | 13 | 1 | 8 | 16 | |
| 752 | PDCD1LG2 levels | PROLV001516 | 2.53 | Protein levels | Hepatocyte | 48 | 1 | 7 | 10 | |
| 753 | Upper respiratory inflammation | RESPI000041 | 2.53 | Respiratory | Muscle / cardiac | 1 | 1 | 1 | 9 | |
| 754 | Cutaneous cysts and sinuses | DERMA000002 | 2.53 | Dermatologic | Cutaneous epithelium | 30 | 0 | 13 | 20 | |
| 755 | Hypoxaemia | RESPI000029 | 2.53 | Respiratory | Vascular | 15 | 2 | 13 | 27 | |
| 756 | NELL2 levels | PROLV001391 | 2.53 | Protein levels | Myeloid | 146 | 3 | 14 | 20 | |
| 757 | CD55 levels | PROLV000345 | 2.52 | Protein levels | Adipose | 54 | 0 | 9 | 16 | |
| 758 | TINAGL1 levels | PROLV002041 | 2.52 | Protein levels | Vascular | 55 | 4 | 8 | 15 | |
| 759 | MSR1/TNFRSF21 ratio | PRORT001560 | 2.52 | Protein ratios | Myeloid | 29 | 3 | 12 | 12 | |
| 760 | ADA levels | PROLV000023 | 2.52 | Protein levels | Myeloid | 17 | 5 | 18 | 32 | |
| 761 | FUT8/VEGFC ratio | PRORT001193 | 2.52 | Protein ratios | Vascular | 3 | 5 | 21 | 43 | |
| 762 | Brain age gap | NIMAG000004 | 2.52 | Neuroimaging | Neural / glial | 1 | 4 | 15 | 36 | |
| 763 | Gut microbial abundance, CAG-177 | GASTR000020 | 2.52 | Gastrointestinal | Salivary epithelium | 0 | 0 | 7 | 5 | |
| 764 | TDRKH levels | PROLV002008 | 2.51 | Protein levels | Vascular | 14 | 4 | 6 | 16 | |
| 765 | NT5C1A levels | PROLV001439 | 2.51 | Protein levels | Muscle / cardiac | 8 | 4 | 16 | 25 | |
| 766 | SCARA5/SCARF2 ratio | PRORT001758 | 2.50 | Protein ratios | Vascular | 4 | 1 | 3 | 18 | |
| 767 | Grey matter volume | NIMAG000023 | 2.49 | Neuroimaging | Stromal / connective | 53 | 0 | 0 | 0 | |
| 768 | Polycythaemia | HEMAT000012 | 2.49 | Hematologic | Vascular | 2 | 2 | 7 | 14 | |
| 769 | DCTN6 levels | PROLV000604 | 2.49 | Protein levels | Vascular | 0 | 4 | 13 | 31 | |
| 770 | CTSF/SMPDL3A ratio | PRORT000802 | 2.49 | Protein ratios | Hepatocyte | 30 | 1 | 7 | 18 | |
| 771 | Kidney transplant | NEPHR000023 | 2.49 | Nephrourologic | Muscle / cardiac | 0 | 1 | 12 | 19 | |
| 772 | ANPEP/DPP4 ratio | PRORT000101 | 2.48 | Protein ratios | Hepatocyte | 25 | 3 | 11 | 18 | |
| 773 | SLC27A4/TDRKH ratio | PRORT001790 | 2.48 | Protein ratios | Stromal / connective | 0 | 1 | 4 | 11 | |
| 774 | CES1 levels | PROLV000405 | 2.48 | Protein levels | Hepatocyte | 148 | 1 | 8 | 13 | |
| 775 | Alzheimer disease | NEURO000018 | 2.48 | Neurologic | Myeloid | 182 | 2 | 8 | 9 | |
| 776 | Benign neoplasm, Melanocytic | MALIG000004 | 2.48 | Malignancy | Stromal / connective | 2 | 0 | 0 | 5 | |
| 777 | TMPRSS11D levels | PROLV002048 | 2.47 | Protein levels | Vascular | 3 | 2 | 5 | 12 | |
| 778 | Testosterone | ENDOC000010 | 2.47 | Endocrine | Hepatocyte | 939 | 2 | 6 | 23 | |
| 779 | KDR/VWF ratio | PRORT001402 | 2.46 | Protein ratios | Vascular | 8 | 2 | 7 | 14 | |
| 780 | TNFRSF11B levels | PROLV002061 | 2.46 | Protein levels | Hepatocyte | 94 | 1 | 6 | 16 | |
| 781 | Premature cardiac beat | CARDI000023 | 2.45 | Cardiac | Neural / glial | 0 | 3 | 12 | 20 | |
| 782 | PRR4 levels | PROLV001642 | 2.45 | Protein levels | Epithelial | 44 | 0 | 8 | 9 | |
| 783 | CLEC14A levels | PROLV000446 | 2.45 | Protein levels | Renal epithelium | 52 | 0 | 7 | 7 | |
| 784 | IGF2R/RNASET2 ratio | PRORT001334 | 2.44 | Protein ratios | Myeloid | 36 | 3 | 13 | 13 | |
| 785 | Atherosclerosis | VASCU000006 | 2.44 | Vascular | Hepatocyte | 177 | 2 | 10 | 20 | |
| 786 | CXCL5 levels | PROLV000584 | 2.44 | Protein levels | Platelet | 0 | 1 | 4 | 10 | |
| 787 | CNTN1/EGFR ratio | PRORT000685 | 2.43 | Protein ratios | Hepatocyte | 69 | 2 | 10 | 12 | |
| 788 | PTPRS levels | PROLV001681 | 2.42 | Protein levels | Lymphocyte | 21 | 2 | 9 | 37 | |
| 789 | LAMA4/NID1 ratio | PRORT001419 | 2.42 | Protein ratios | Vascular | 14 | 5 | 12 | 24 | |
| 790 | CSF volume | NIMAG000018 | 2.42 | Neuroimaging | Stromal / connective | 16 | 2 | 2 | 6 | |
| 791 | PLAUR/TREM2 ratio | PRORT001680 | 2.42 | Protein ratios | Hepatocyte | 73 | 3 | 12 | 16 | |
| 792 | Polycystic ovary syndrome | REPRO000024 | 2.42 | Reproductive | Granulosa cell | 29 | 2 | 4 | 19 | |
| 793 | Gastric ulcer | GASTR000048 | 2.41 | Gastrointestinal | Lymphocyte | 3 | 1 | 7 | 27 | |
| 794 | Lactose intolerance | METBL000003 | 2.41 | Metabolic | Renal epithelium | 0 | 0 | 7 | 4 | |
| 795 | ORM1 levels | PROLV001473 | 2.41 | Protein levels | Myeloid | 16 | 1 | 9 | 12 | |
| 796 | PON3 levels | PROLV001602 | 2.41 | Protein levels | Hepatocyte | 81 | 4 | 9 | 26 | |
| 797 | White matter microstructure | NIMAG000013 | 2.40 | Neuroimaging | Neural / glial | 96 | 0 | 0 | 3 | |
| 798 | DYNLL1 levels | PROLV000666 | 2.40 | Protein levels | B / plasma cell | 0 | 1 | 4 | 4 | |
| 799 | Short-chain fatty acids | METAB000053 | 2.40 | Metabolites | Granulosa cell | 20 | 5 | 12 | 17 | |
| 800 | ANGPT2 levels | PROLV000094 | 2.40 | Protein levels | Hepatocyte | 72 | 3 | 10 | 21 | |
| 801 | PLAT levels | PROLV001571 | 2.39 | Protein levels | Hepatocyte | 64 | 2 | 8 | 18 | |
| 802 | MPIG6B/PDGFB ratio | PRORT001557 | 2.37 | Protein ratios | Myeloid | 3 | 4 | 11 | 21 | |
| 803 | DNAJA2/FIS1 ratio | PRORT000920 | 2.37 | Protein ratios | Granulosa cell | 0 | 4 | 13 | 24 | |
| 804 | GMPR2 levels | PROLV000903 | 2.37 | Protein levels | Lymphocyte | 3 | 3 | 11 | 40 | |
| 805 | CRTAC1 levels | PROLV000529 | 2.37 | Protein levels | Myeloid | 136 | 2 | 12 | 16 | |
| 806 | Osteopenia | MSKEL000009 | 2.36 | Musculoskeletal | Adipose | 0 | 2 | 10 | 35 | |
| 807 | CYTL1 levels | PROLV000589 | 2.36 | Protein levels | Stromal / connective | 2 | 2 | 4 | 6 | |
| 808 | PLA2G4A/PPP1R12A ratio | PRORT001673 | 2.34 | Protein ratios | Hepatocyte | 3 | 4 | 10 | 25 | |
| 809 | TMSB10/ZBTB16 ratio | PRORT001842 | 2.34 | Protein ratios | Muscle / cardiac | 29 | 4 | 8 | 25 | |
| 810 | DKK4/REG1A ratio | PRORT000909 | 2.34 | Protein ratios | Hepatocyte | 32 | 2 | 8 | 16 | |
| 811 | EFNA1/PIK3IP1 ratio | PRORT000989 | 2.34 | Protein ratios | Hepatocyte | 29 | 2 | 10 | 21 | |
| 812 | CXCL17/SFTPA2 ratio | PRORT000824 | 2.33 | Protein ratios | Myeloid | 3 | 2 | 8 | 18 | |
| 813 | AGRP/NPY ratio | PRORT000050 | 2.33 | Protein ratios | Hepatocyte | 28 | 1 | 9 | 10 | |
| 814 | CD99L2 levels | PROLV000364 | 2.33 | Protein levels | Hepatocyte | 88 | 1 | 7 | 18 | |
| 815 | CDCP1/MSR1 ratio | PRORT000544 | 2.33 | Protein ratios | Myeloid | 26 | 2 | 10 | 13 | |
| 816 | ICAM5 levels | PROLV001008 | 2.33 | Protein levels | Myeloid | 6 | 0 | 3 | 9 | |
| 817 | DLL4 levels | PROLV000627 | 2.33 | Protein levels | Epithelial | 2 | 1 | 10 | 16 | |
| 818 | Family history, Alzheimer disease | NEURO000007 | 2.32 | Neurologic | Vascular | 35 | 0 | 1 | 3 | |
| 819 | Metabolic disorder | METBL000014 | 2.32 | Metabolic | Hepatocyte | 114 | 1 | 7 | 15 | |
| 820 | JAM2 levels | PROLV001124 | 2.32 | Protein levels | Vascular | 4 | 0 | 5 | 7 | |
| 821 | XPNPEP2 levels | PROLV002199 | 2.32 | Protein levels | Hepatocyte | 67 | 2 | 9 | 14 | |
| 822 | Keloid and scarring | DERMA000041 | 2.32 | Dermatologic | Muscle / cardiac | 17 | 2 | 3 | 19 | |
| 823 | Spine surgery | MSKEL000051 | 2.32 | Musculoskeletal | Stromal / connective | 0 | 2 | 7 | 14 | |
| 824 | APOM levels | PROLV000128 | 2.32 | Protein levels | Hepatocyte | 122 | 2 | 8 | 20 | |
| 825 | ENAH levels | PROLV000702 | 2.31 | Protein levels | Vascular | 0 | 1 | 6 | 20 | |
| 826 | BPIFB2 levels | PROLV000211 | 2.31 | Protein levels | Hepatocyte | 112 | 1 | 6 | 17 | |
| 827 | SERPINF1 levels | PROLV001832 | 2.31 | Protein levels | Vascular | 7 | 0 | 6 | 8 | |
| 828 | CRTAM/TNFRSF9 ratio | PRORT000774 | 2.30 | Protein ratios | Lymphocyte | 7 | 3 | 17 | 30 | |
| 829 | Brain general volume | NIMAG000015 | 2.30 | Neuroimaging | Neural / glial | 5 | 2 | 6 | 15 | |
| 830 | PDLIM7/SRC ratio | PRORT001655 | 2.30 | Protein ratios | Myeloid | 12 | 3 | 7 | 20 | |
| 831 | LRP11/NECTIN2 ratio | PRORT001460 | 2.30 | Protein ratios | Vascular | 14 | 2 | 10 | 10 | |
| 832 | Labour complication | REPRO000037 | 2.29 | Reproductive | Stromal / connective | 0 | 1 | 4 | 7 | |
| 833 | Operation, urological | NEPHR000016 | 2.29 | Nephrourologic | Vascular | 16 | 0 | 6 | 18 | |
| 834 | MAPK9 levels | PROLV001271 | 2.28 | Protein levels | Vascular | 0 | 3 | 8 | 17 | |
| 835 | HSPB1 levels | PROLV000997 | 2.28 | Protein levels | Platelet | 16 | 3 | 3 | 13 | |
| 836 | CA2/PSMG3 ratio | PRORT000277 | 2.28 | Protein ratios | Lymphocyte | 3 | 3 | 4 | 19 | |
| 837 | B3GNT7 levels | PROLV000170 | 2.27 | Protein levels | Muscle / cardiac | 72 | 2 | 13 | 24 | |
| 838 | COMP/THBS4 ratio | PRORT000714 | 2.27 | Protein ratios | Neural / glial | 1 | 5 | 15 | 26 | |
| 839 | TSTA3 levels | PROLV002118 | 2.27 | Protein levels | Vascular | 10 | 3 | 7 | 12 | |
| 840 | PEPD levels | PROLV001536 | 2.26 | Protein levels | Myeloid | 66 | 2 | 7 | 7 | |
| 841 | DKK4 levels | PROLV000622 | 2.25 | Protein levels | Vascular | 53 | 2 | 10 | 18 | |
| 842 | MAN1A2 levels | PROLV001260 | 2.24 | Protein levels | Myeloid | 160 | 3 | 12 | 14 | |
| 843 | TIMM8A levels | PROLV002037 | 2.24 | Protein levels | Vascular | 17 | 4 | 8 | 16 | |
| 844 | Hearing aid use | AUDIO000011 | 2.24 | Auditory | Epithelial | 12 | 1 | 5 | 9 | |
| 845 | METAP2 levels | PROLV001304 | 2.24 | Protein levels | Stromal / connective | 8 | 5 | 13 | 36 | |
| 846 | DLL1/EFEMP1 ratio | PRORT000914 | 2.23 | Protein ratios | Hepatocyte | 33 | 2 | 7 | 20 | |
| 847 | EFEMP1 levels | PROLV000679 | 2.23 | Protein levels | Hepatocyte | 115 | 1 | 5 | 11 | |
| 848 | CSF1/LTBR ratio | PRORT000778 | 2.23 | Protein ratios | Myeloid | 29 | 5 | 13 | 24 | |
| 849 | PRTFDC1 levels | PROLV001649 | 2.23 | Protein levels | Platelet | 28 | 3 | 11 | 12 | |
| 850 | CDH17 levels | PROLV000373 | 2.23 | Protein levels | Myeloid | 57 | 1 | 5 | 14 | |
| 851 | DFFA levels | PROLV000615 | 2.23 | Protein levels | Stromal / connective | 1 | 3 | 10 | 13 | |
| 852 | PRCP/SELE ratio | PRORT001709 | 2.22 | Protein ratios | Granulosa cell | 0 | 2 | 6 | 18 | |
| 853 | CPQ levels | PROLV000509 | 2.22 | Protein levels | Epithelial | 108 | 2 | 7 | 18 | |
| 854 | COL9A1 levels | PROLV000493 | 2.21 | Protein levels | Stromal / connective | 7 | 6 | 17 | 22 | |
| 855 | PPP3R1 levels | PROLV001620 | 2.21 | Protein levels | Myeloid | 20 | 2 | 10 | 18 | |
| 856 | MSTN levels | PROLV001345 | 2.20 | Protein levels | Muscle / cardiac | 17 | 2 | 9 | 17 | |
| 857 | CD99 levels | PROLV000363 | 2.20 | Protein levels | Granulosa cell | 27 | 1 | 7 | 9 | |
| 858 | IGSF3 levels | PROLV001038 | 2.20 | Protein levels | Hepatocyte | 95 | 2 | 8 | 28 | |
| 859 | CD276 levels | PROLV000326 | 2.19 | Protein levels | Adipose | 14 | 0 | 4 | 4 | |
| 860 | PTGES2 levels | PROLV001665 | 2.19 | Protein levels | Myeloid | 1 | 3 | 13 | 21 | |
| 861 | Consultant specialty, general surgery | MISCL000017 | 2.19 | Miscellaneous | Neural / glial | 3 | 2 | 4 | 10 | |
| 862 | Heart rate | CARDI000021 | 2.19 | Cardiac | Muscle / cardiac | 1,425 | 2 | 8 | 13 | |
| 863 | Trihexosylceramides | LIPID000073 | 2.19 | Lipids | Granulosa cell | 7 | 2 | 5 | 4 | |
| 864 | Ventricular volume | CARDI000015 | 2.18 | Cardiac | Muscle / cardiac | 83 | 2 | 7 | 15 | |
| 865 | AMBP/EFEMP1 ratio | PRORT000085 | 2.18 | Protein ratios | Hepatocyte | 39 | 2 | 10 | 11 | |
| 866 | Pregnancy complication, haemorrhage | REPRO000030 | 2.18 | Reproductive | Stromal / connective | 13 | 2 | 3 | 14 | |
| 867 | FCRLB levels | PROLV000788 | 2.18 | Protein levels | B / plasma cell | 86 | 3 | 8 | 21 | |
| 868 | AKR1B1 levels | PROLV000072 | 2.17 | Protein levels | Stromal / connective | 11 | 7 | 10 | 27 | |
| 869 | TALDO1 levels | PROLV001991 | 2.17 | Protein levels | Lymphocyte | 8 | 3 | 10 | 40 | |
| 870 | ASGR1/GGT5 ratio | PRORT000148 | 2.17 | Protein ratios | Hepatocyte | 60 | 1 | 9 | 18 | |
| 871 | LTBR/TNFRSF14 ratio | PRORT001467 | 2.16 | Protein ratios | Stromal / connective | 0 | 4 | 11 | 23 | |
| 872 | B4GALT1 levels | PROLV000171 | 2.16 | Protein levels | Renal epithelium | 30 | 0 | 6 | 1 | |
| 873 | Urinary tract infection | IMMUN000074 | 2.15 | Immunologic | Neural / glial | 1 | 1 | 3 | 7 | |
| 874 | FCN1 levels | PROLV000781 | 2.15 | Protein levels | Myeloid | 95 | 2 | 8 | 18 | |
| 875 | Corns and callosities | DERMA000023 | 2.14 | Dermatologic | Cutaneous epithelium | 3 | 0 | 3 | 3 | |
| 876 | ITPA levels | PROLV001121 | 2.14 | Protein levels | Muscle / cardiac | 0 | 3 | 7 | 21 | |
| 877 | ATXN10 levels | PROLV000164 | 2.14 | Protein levels | Vascular | 7 | 3 | 9 | 20 | |
| 878 | CD300LG/CD93 ratio | PRORT000433 | 2.14 | Protein ratios | Vascular | 3 | 2 | 5 | 16 | |
| 879 | PGR levels | PROLV001548 | 2.14 | Protein levels | B / plasma cell | 21 | 3 | 12 | 30 | |
| 880 | Intestinal disorder | GASTR000012 | 2.13 | Gastrointestinal | Neural / glial | 8 | 2 | 6 | 13 | |
| 881 | Gut microbial abundance, Rikenellaceae | GASTR000034 | 2.13 | Gastrointestinal | Neural / glial | 0 | 6 | 10 | 28 | |
| 882 | LTBP2/PDGFRA ratio | PRORT001465 | 2.13 | Protein ratios | Myeloid | 4 | 3 | 9 | 8 | |
| 883 | CKB levels | PROLV000440 | 2.13 | Protein levels | Muscle / cardiac | 40 | 3 | 5 | 15 | |
| 884 | ITGB5 levels | PROLV001114 | 2.13 | Protein levels | Platelet | 18 | 2 | 5 | 10 | |
| 885 | ISLR2 levels | PROLV001101 | 2.13 | Protein levels | Granulosa cell | 65 | 4 | 11 | 16 | |
| 886 | TCTN3 levels | PROLV002005 | 2.13 | Protein levels | Hepatocyte | 89 | 3 | 10 | 20 | |
| 887 | Cardiovascular age gap | CARDI000001 | 2.12 | Cardiac | Muscle / cardiac | 27 | 3 | 6 | 16 | |
| 888 | GAL levels | PROLV000847 | 2.12 | Protein levels | Hepatocyte | 129 | 1 | 11 | 16 | |
| 889 | TNFSF11 levels | PROLV002076 | 2.11 | Protein levels | Hepatocyte | 28 | 3 | 10 | 14 | |
| 890 | Corrective lens use | OPHTH000032 | 2.11 | Ophthalmic | Neural / glial | 66 | 8 | 14 | 25 | |
| 891 | CDH5 levels | PROLV000376 | 2.11 | Protein levels | Vascular | 33 | 3 | 9 | 25 | |
| 892 | CD164 levels | PROLV000313 | 2.11 | Protein levels | Myeloid | 20 | 2 | 10 | 12 | |
| 893 | APP/NID2 ratio | PRORT000129 | 2.11 | Protein ratios | Stromal / connective | 0 | 2 | 6 | 11 | |
| 894 | Gut microbial abundance, Alistipes | GASTR000018 | 2.11 | Gastrointestinal | Neural / glial | 0 | 6 | 11 | 30 | |
| 895 | CLEC1B/DAB2 ratio | PRORT000633 | 2.11 | Protein ratios | Lymphocyte | 9 | 4 | 15 | 43 | |
| 896 | FOLH1 levels | PROLV000821 | 2.10 | Protein levels | Hepatocyte | 7 | 0 | 3 | 10 | |
| 897 | DNAJB1/STIP1 ratio | PRORT000930 | 2.10 | Protein ratios | Hepatocyte | 29 | 2 | 8 | 12 | |
| 898 | Anaemia of chronic disease | HEMAT000002 | 2.10 | Hematologic | Hepatocyte | 4 | 3 | 6 | 15 | |
| 899 | Microscopic colitis | IMMUN000033 | 2.10 | Immunologic | Muscle / cardiac | 7 | 1 | 4 | 12 | |
| 900 | PLG levels | PROLV001577 | 2.10 | Protein levels | Granulosa cell | 46 | 5 | 14 | 28 | |
| 901 | HPGDS levels | PROLV000985 | 2.10 | Protein levels | Myeloid | 40 | 4 | 11 | 22 | |
| 902 | GZMA/TNFRSF4 ratio | PRORT001261 | 2.10 | Protein ratios | Lymphocyte | 36 | 3 | 15 | 35 | |
| 903 | ROBO1 levels | PROLV001749 | 2.10 | Protein levels | Myeloid | 129 | 2 | 7 | 15 | |
| 904 | HYOU1/TGFBR3 ratio | PRORT001317 | 2.09 | Protein ratios | Hepatocyte | 27 | 2 | 8 | 23 | |
| 905 | CTSE levels | PROLV000563 | 2.09 | Protein levels | Gastrointestinal epithelium | 50 | 0 | 5 | 6 | |
| 906 | PECAM1 levels | PROLV001534 | 2.08 | Protein levels | Myeloid | 39 | 2 | 7 | 17 | |
| 907 | DKK3 levels | PROLV000621 | 2.07 | Protein levels | Myeloid | 56 | 3 | 10 | 17 | |
| 908 | CNTNAP4 levels | PROLV000481 | 2.07 | Protein levels | Lymphocyte | 38 | 0 | 7 | 16 | |
| 909 | Brain MRI signal intensity | NIMAG000003 | 2.07 | Neuroimaging | Neural / glial | 143 | 4 | 7 | 15 | |
| 910 | SRC/TBL1X ratio | PRORT001814 | 2.06 | Protein ratios | Platelet | 1 | 4 | 11 | 15 | |
| 911 | IGFBP3 levels | PROLV001030 | 2.06 | Protein levels | Hepatocyte | 67 | 2 | 10 | 17 | |
| 912 | CD244/FCRL6 ratio | PRORT000408 | 2.06 | Protein ratios | Lymphocyte | 9 | 2 | 12 | 33 | |
| 913 | UBXN1 levels | PROLV002134 | 2.06 | Protein levels | Lymphocyte | 5 | 4 | 15 | 38 | |
| 914 | DOK2/PDLIM7 ratio | PRORT000940 | 2.06 | Protein ratios | Muscle / cardiac | 6 | 4 | 14 | 19 | |
| 915 | VWA1 levels | PROLV002179 | 2.06 | Protein levels | Hepatocyte | 83 | 2 | 10 | 14 | |
| 916 | Childhood maltreatment | PSYCH000052 | 2.06 | Psychiatric | Vascular | 0 | 1 | 4 | 7 | |
| 917 | CXCL14 levels | PROLV000580 | 2.06 | Protein levels | Myeloid | 0 | 3 | 8 | 16 | |
| 918 | MEGF10 levels | PROLV001293 | 2.06 | Protein levels | Muscle / cardiac | 25 | 4 | 11 | 30 | |
| 919 | OGN levels | PROLV001465 | 2.06 | Protein levels | Epithelial | 12 | 0 | 9 | 4 | |
| 920 | Hearing loss, age-related | AUDIO000006 | 2.06 | Auditory | Neural / glial | 4 | 3 | 13 | 14 | |
| 921 | SIGLEC7 levels | PROLV001863 | 2.06 | Protein levels | Myeloid | 20 | 1 | 13 | 11 | |
| 922 | Facial ageing | DERMA000039 | 2.06 | Dermatologic | Melanocyte | 22 | 0 | 0 | 0 | |
| 923 | RHOC/TBCC ratio | PRORT001741 | 2.06 | Protein ratios | Myeloid | 0 | 4 | 10 | 12 | |
| 924 | APOE levels | PROLV000124 | 2.05 | Protein levels | Neural / glial | 46 | 4 | 13 | 21 | |
| 925 | Amygdala volume | NIMAG000014 | 2.04 | Neuroimaging | Hepatocyte | 32 | 0 | 1 | 7 | |
| 926 | Biliary cirrhosis | HPBIL000005 | 2.04 | Hepatopancreatobiliary | Salivary epithelium | — | 0 | 12 | 10 | |
| 927 | MYO9B levels | PROLV001362 | 2.03 | Protein levels | Myeloid | 14 | 1 | 7 | 10 | |
| 928 | Bursitis | MSKEL000059 | 2.03 | Musculoskeletal | Hematopoietic progenitor | 0 | 1 | 3 | 7 | |
| 929 | FYN levels | PROLV000843 | 2.03 | Protein levels | Muscle / cardiac | 0 | 3 | 12 | 32 | |
| 930 | STX16 levels | PROLV001967 | 2.03 | Protein levels | Muscle / cardiac | 7 | 4 | 5 | 17 | |
| 931 | BCAN/KLK6 ratio | PRORT000216 | 2.02 | Protein ratios | Myeloid | 11 | 2 | 7 | 12 | |
| 932 | ADAM22 levels | PROLV000027 | 2.02 | Protein levels | Adipose | 54 | 0 | 6 | 8 | |
| 933 | Gastro-oesophageal reflux disease, GERD | GASTR000045 | 2.02 | Gastrointestinal | Neural / glial | 38 | 2 | 8 | 15 | |
| 934 | SNX5 levels | PROLV001914 | 2.02 | Protein levels | Myeloid | 6 | 3 | 11 | 24 | |
| 935 | TMSB10/TRIAP1 ratio | PRORT001840 | 2.01 | Protein ratios | Myeloid | 2 | 3 | 7 | 14 | |
| 936 | PCDHB15 levels | PROLV001509 | 2.00 | Protein levels | Vascular | 46 | 2 | 6 | 9 | |
| 937 | Gout | METBL000043 | 2.00 | Metabolic | Hepatocyte | 506 | 1 | 10 | 10 | |
| 938 | Liver fat | HPBIL000023 | 2.00 | Hepatopancreatobiliary | Neural / glial | 33 | 2 | 5 | 16 | |
| 939 | PLA2G2A levels | PROLV001568 | 2.00 | Protein levels | Myeloid | 20 | 3 | 9 | 17 | |
| 940 | CD99L2/CPM ratio | PRORT000538 | 1.99 | Protein ratios | Hepatocyte | 28 | 2 | 10 | 16 | |
| 941 | Sleep apnoea | RESPI000035 | 1.99 | Respiratory | Neural / glial | 73 | 1 | 2 | 10 | |
| 942 | ADGRE2/CD58 ratio | PRORT000028 | 1.99 | Protein ratios | Myeloid | 43 | 3 | 11 | 17 | |
| 943 | PODXL levels | PROLV001595 | 1.99 | Protein levels | Vascular | 18 | 1 | 5 | 12 | |
| 944 | Creatine metabolites | METAB000058 | 1.99 | Metabolites | Muscle / cardiac | 0 | 2 | 7 | 10 | |
| 945 | LAT2/SERPINB1 ratio | PRORT001431 | 1.99 | Protein ratios | Hepatocyte | 1 | 4 | 13 | 30 | |
| 946 | XRCC4 levels | PROLV002200 | 1.98 | Protein levels | Myeloid | 0 | 4 | 9 | 17 | |
| 947 | LTB4R levels | PROLV001241 | 1.98 | Protein levels | Myeloid | 8 | 3 | 12 | 18 | |
| 948 | STAB2 levels | PROLV001956 | 1.97 | Protein levels | Granulosa cell | 78 | 2 | 11 | 19 | |
| 949 | ASGR1/DCBLD2 ratio | PRORT000147 | 1.97 | Protein ratios | Hepatocyte | 92 | 3 | 9 | 19 | |
| 950 | ST13 levels | PROLV001951 | 1.97 | Protein levels | Lymphocyte | 2 | 5 | 15 | 39 | |
| 951 | CCL15/CCL23 ratio | PRORT000341 | 1.97 | Protein ratios | Myeloid | 7 | 1 | 6 | 27 | |
| 952 | CCL13/CCL2 ratio | PRORT000338 | 1.96 | Protein ratios | Myeloid | 8 | 3 | 7 | 10 | |
| 953 | PDGFRA levels | PROLV001525 | 1.96 | Protein levels | Hepatocyte | 55 | 2 | 4 | 14 | |
| 954 | Physical decline | AGING000005 | 1.96 | Aging | Muscle / cardiac | 0 | 4 | 15 | 14 | |
| 955 | LGALS8/VWF ratio | PRORT001455 | 1.95 | Protein ratios | Granulosa cell | 1 | 4 | 10 | 24 | |
| 956 | IL18R1 levels | PROLV001056 | 1.95 | Protein levels | Hepatocyte | 88 | 1 | 5 | 7 | |
| 957 | Phosphate | METAB000048 | 1.95 | Metabolites | Hepatocyte | 604 | 1 | 7 | 10 | |
| 958 | SMAD5 levels | PROLV001897 | 1.95 | Protein levels | Myeloid | 95 | 2 | 6 | 11 | |
| 959 | IL19 levels | PROLV001058 | 1.93 | Protein levels | Vascular | 20 | 0 | 7 | 23 | |
| 960 | CCL14 levels | PROLV000280 | 1.93 | Protein levels | Vascular | 34 | 3 | 9 | 13 | |
| 961 | DSG3/DSG4 ratio | PRORT000952 | 1.93 | Protein ratios | Cutaneous epithelium | 11 | 1 | 6 | 11 | |
| 962 | Leucine | METAB000025 | 1.93 | Metabolites | Hepatocyte | 24 | 3 | 8 | 21 | |
| 963 | GORASP2 levels | PROLV000911 | 1.92 | Protein levels | Vascular | 13 | 2 | 7 | 27 | |
| 964 | Cardiac pacemaker | CARDI000049 | 1.92 | Cardiac | Muscle / cardiac | 22 | 3 | 14 | 22 | |
| 965 | Epigenetic age acceleration | AGING000002 | 1.91 | Aging | Hematopoietic progenitor | 25 | 1 | 3 | 22 | |
| 966 | CAMK1D levels | PROLV000259 | 1.90 | Protein levels | Hepatocyte | 9 | 2 | 8 | 12 | |
| 967 | CD300LG/DSG2 ratio | PRORT000435 | 1.90 | Protein ratios | Vascular | 16 | 1 | 5 | 9 | |
| 968 | F9 levels | PROLV000750 | 1.90 | Protein levels | Myeloid | 24 | 6 | 12 | 31 | |
| 969 | KIAA0040 levels | PROLV001136 | 1.90 | Protein levels | Stromal / connective | 0 | 2 | 8 | 14 | |
| 970 | Gastrointestinal polyps | GASTR000005 | 1.90 | Gastrointestinal | Respiratory epithelium | 0 | 0 | 4 | 11 | |
| 971 | Depression or anxiety | PSYCH000025 | 1.90 | Psychiatric | Neural / glial | 52 | 4 | 9 | 10 | |
| 972 | LY6D/NECTIN4 ratio | PRORT001468 | 1.90 | Protein ratios | Cutaneous epithelium | 13 | 0 | 8 | 11 | |
| 973 | Cutaneous haemangioma | DERMA000003 | 1.90 | Dermatologic | Myeloid | 1 | 1 | 7 | 12 | |
| 974 | CPXM1/MDK ratio | PRORT000735 | 1.90 | Protein ratios | Hematopoietic progenitor | 20 | 3 | 6 | 22 | |
| 975 | HYOU1/THBD ratio | PRORT001318 | 1.89 | Protein ratios | Hepatocyte | 54 | 2 | 7 | 23 | |
| 976 | SIGLEC9 levels | PROLV001865 | 1.89 | Protein levels | Hepatocyte | 118 | 1 | 6 | 11 | |
| 977 | PMVK levels | PROLV001590 | 1.89 | Protein levels | Myeloid | 34 | 3 | 8 | 12 | |
| 978 | NID1/NID2 ratio | PRORT001588 | 1.88 | Protein ratios | Lymphocyte | 3 | 3 | 8 | 25 | |
| 979 | SERPINE1/USP8 ratio | PRORT001779 | 1.88 | Protein ratios | Lymphocyte | 0 | 4 | 16 | 40 | |
| 980 | APRT/NSFL1C ratio | PRORT000136 | 1.88 | Protein ratios | Lymphocyte | 0 | 2 | 9 | 25 | |
| 981 | MYOC/RGMB ratio | PRORT001567 | 1.88 | Protein ratios | Vascular | 11 | 2 | 8 | 15 | |
| 982 | GRAP2/PTPN6 ratio | PRORT001244 | 1.88 | Protein ratios | Hepatocyte | 6 | 2 | 7 | 12 | |
| 983 | LGALS8/SOD2 ratio | PRORT001453 | 1.88 | Protein ratios | Myeloid | 6 | 6 | 16 | 28 | |
| 984 | BCAN levels | PROLV000182 | 1.87 | Protein levels | Myeloid | 115 | 2 | 7 | 10 | |
| 985 | GSTA3 levels | PROLV000940 | 1.87 | Protein levels | Hepatocyte | 38 | 3 | 12 | 25 | |
| 986 | NBL1/TGFBR2 ratio | PRORT001573 | 1.87 | Protein ratios | Vascular | 18 | 1 | 7 | 15 | |
| 987 | Triglycerides/phosphoglycerides | LIPID000042 | 1.87 | Lipids | Hepatocyte | 839 | 3 | 8 | 17 | |
| 988 | CLIP2/DNAJA2 ratio | PRORT000665 | 1.87 | Protein ratios | Muscle / cardiac | 0 | 3 | 10 | 18 | |
| 989 | Malocclusion | DENTA000008 | 1.87 | Dental | Stromal / connective | 0 | 0 | 1 | 2 | |
| 990 | FOLR1 levels | PROLV000822 | 1.86 | Protein levels | Renal epithelium | 21 | 0 | 6 | 4 | |
| 991 | PRAP1 levels | PROLV001623 | 1.86 | Protein levels | Hematopoietic progenitor | 16 | 2 | 6 | 11 | |
| 992 | GFRA3/LAYN ratio | PRORT001211 | 1.86 | Protein ratios | Adipose | 4 | 3 | 4 | 12 | |
| 993 | SPTLC1 levels | PROLV001941 | 1.85 | Protein levels | Myeloid | 0 | 1 | 7 | 15 | |
| 994 | Vitreous disorder | OPHTH000047 | 1.85 | Ophthalmic | Neural / glial | 1 | 2 | 6 | 7 | |
| 995 | Migraine | NEURO000010 | 1.85 | Neurologic | Neural / glial | 16 | 0 | 1 | 5 | |
| 996 | AREG levels | PROLV000132 | 1.85 | Protein levels | Vascular | 28 | 0 | 10 | 8 | |
| 997 | FUT3 levels | PROLV000837 | 1.85 | Protein levels | Neural / glial | 2 | 2 | 5 | 17 | |
| 998 | Chronic kidney disease | NEPHR000001 | 1.84 | Nephrourologic | Hepatocyte | 63 | 1 | 4 | 8 | |
| 999 | Organic acids | METAB000068 | 1.84 | Metabolites | Neural / glial | 3 | 0 | 1 | 8 | |
| 1000 | SLC51B levels | PROLV001883 | 1.84 | Protein levels | B / plasma cell | 4 | 0 | 6 | 9 |